﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v6.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-07-10T09:26:12+00:00</ReturnTs>
    <TaxPeriodEndDt>2024-08-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>350921680</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>CROWE LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>225 West Wacker Drive Suite 2600</AddressLine1Txt>
        <CityNm>Chicago</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>606061224</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-09-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>362256036</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>Rehabilitation Institute of Chicago</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>REHA</BusinessNameControlTxt>
      <PhoneNum>3122381000</PhoneNum>
      <USAddress>
        <AddressLine1Txt>355 EAST ERIE STREET</AddressLine1Txt>
        <CityNm>CHICAGO</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>60611</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>Jonathan M Tingstad</PersonNm>
      <PersonTitleTxt>Senior VP/CFO</PersonTitleTxt>
      <SignatureDt>2025-07-10</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>MALLORY FAIRLESS</PreparerPersonNm>
      <PTIN>P01321579</PTIN>
      <PhoneNum>3128997000</PhoneNum>
      <PreparationDt>2025-07-10</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="15">
    <IRS990 documentId="IRS990" softwareId="23017437" softwareVersionNum="2023v6.0">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>SHIRLEY RYAN ABILITYLAB</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfcrBusinessName>
        <BusinessNameLine1Txt>Pablo Celnik MD CEO</BusinessNameLine1Txt>
      </PrincipalOfcrBusinessName>
      <USAddress>
        <AddressLine1Txt>355 EAST ERIE STREET</AddressLine1Txt>
        <CityNm>CHICAGO</CityNm>
        <StateAbbreviationCd>IL</StateAbbreviationCd>
        <ZIPCd>60611</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>656589058</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>www.sralab.org</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1951</FormationYr>
      <LegalDomicileStateCd>IL</LegalDomicileStateCd>
      <ActivityOrMissionDesc>The Rehabilitation Institute of Chicago DBA Shirley Ryan AbilityLab (SRAlab) is dedicated to providing the best patient outcomes through the highest-quality clinical care, translational research, scientific discovery and education.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>18</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>16</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>3240</TotalEmployeeCnt>
      <TotalVolunteersCnt>228</TotalVolunteersCnt>
      <TotalGrossUBIAmt>7711272</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>3625321</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>60956794</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>57586903</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>338508584</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>370239401</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>25098579</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>16047616</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>2764777</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>2857235</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>427328734</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>446731155</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>7851397</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>6887779</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>240895434</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>265660592</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>90000</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>90000</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>2084540</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>148817852</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>158783134</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>397654683</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>431421505</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>29674051</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>15309650</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>1180017214</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>1266946907</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>416312517</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>407304886</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>763704697</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>859642021</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>SRAlab is dedicated to providing the best patient outcomes through the highest-quality clinical care, translational research, scientific discovery and education.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>289304828</ExpenseAmt>
      <RevenueAmt>349813189</RevenueAmt>
      <Desc>The Rehabilitation Institute of Chicago (RIC) was founded in 1951 as, an Illinois not-for-profit corporation. In 2017 RIC, with 182 beds, began doing business as the Shirley Ryan Abilitylab (SRAlab) and moved to a new building with 242 licensed beds. This move brought not only a physical change of address but a whole new model to the field of rehabilitation. Upon opening the 1.2-million-square-foot building SRAlab became the first-ever "translational" rehabilitation research hospital in which clinicians, scientists, innovators and technologists work together in the same space, surrounding patients, discovering new approaches and applying (or "translating") research in real time. SRAlab's vision is to advance human ability through science and research. The organization has earned the distinction of being named the nation's #1-ranked provider of comprehensive physical medicine and rehabilitation care to patients from around the world every year since the designation's inception in 1992 by U.S. News &amp; World Report - a record for any U.S. hospital. In addition to being a large rehabilitation hospital SRAlab is the nation's largest rehabilitation research enterprise, advancing the field globally through innovation of the most advanced treatments and technologies. For FY 2024 SRAlab's system of care included a 262-bed hospital located at 355 East Erie Street in Chicago and numerous outpatient programs in the Chicago metropolitan area and surrounding suburbs. In addition, we manage the rehabilitation service line in several acute care hospitals through our strategic alliance platform, primarily in the Chicagoland area. In addition, we completed our first full year managing the inpatient rehabilitation service at Hennepin Healthcare. The Corporation offers a comprehensive range of inpatient, day rehabilitation and outpatient rehabilitation services. Inpatient rehabilitation services are provided using an interdisciplinary approach with a team bringing unique skills and knowledge to ensure patients achieve the best possible outcomes. Day rehabilitation is a similar model to inpatient in that it consists of an interdisciplinary approach for individuals. Once the patient does not require 24-hour nursing care and daily medical management, we are able to transition patients to the day rehabilitation model. Outpatient care is typically a singular discipline (e.g., physical therapy) and offers various levels of therapeutic intensity, depending on the patient's needs and goals. In FY 2024 we grew our net operating income and operating EBITDA from the previous year. Our total net revenue grew by 8.9% resulting in $1.7M in net operating income, $3.6M better than budget. We improved financial ratios and exceeded debt covenant metrics, including debt service coverage ratio and days cash on hand (more than 380 days at year-end). In addition, Fitch Ratings affirmed Shirley Ryan AbilityLab's A credit rating and revised the outlook to Positive. Inpatient admissions to the Flagship facility grew 1%, particularly through our global network and national admissions with 4% growth from prior year. Both the day rehabilitation and the outpatient therapy programs grew year over year by 3% and 2% respectively. Our total research grant portfolio exceeds $150M. SRAlab offers the ability for patients to participate in research at the same time they are receiving clinical care. Since inception SRAlab's has worked relentlessly to develop and implement interventions that drive the very best outcomes. SRAlab serves patients with the most complex conditions with multiple medical and rehabilitation issues. The Advancement Department is in year 2 of the Accelerate Ability Campaign with an aim to raise money to support research initiatives and quality of life programs. We raised ~ $80M and secured more than $20M in bequests toward a $100M goal. We continue our planning for a new and unique partnership with Henry Ford Healthcare, the Gilbert Family Foundation and Michigan State University which will allow us to bring our world-class care to the Detroit market. Groundbreaking for the new tower in downtown Detroit occurred this year. This tower will house 72 rehabilitation beds managed through a joint venture between Henry Ford Health System and Shirley Ryan AbilityLab. It is the mission of SRAlab to not only focus on our patients but to also elevate the entire rehabilitation field. In FY 2024, SRAlab clinicians, physicians and researchers shared numerous presentations to various professional audiences as well as published papers on scientific and clinical advancements. SRAlab continues to focus on providing a number of unreimbursed services improving the quality of life for our patients. These services include vocational rehabilitation, virtual education and consumer health resources available free of charge to all through our LIFE (Learning Innovation, Family and Empowerment) Center website, and adaptive sports and fitness services for children and adults. SRAlab continues to support the Robert R. McCormick Center for Hope &amp; Equity to provide needed education for our staff and wraparound services for our patients who come from vulnerable communities.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>59925760</ExpenseAmt>
        <GrantAmt>6887779</GrantAmt>
        <RevenueAmt>10389821</RevenueAmt>
        <Desc>Research Program: SRAlab's Research Program is the world's largest physical rehabilitation research enterprise in pursuit of clinical advancement through scientific discovery. In Fiscal Year 2024, the Research Program had approximately 140 research projects underway, funded by more than $170 million in grants and donations from both private and public sources. Its experts regularly publish research in the world's foremost medical journals, including the Journal of the American Medical Association (JAMA) and its European equivalent, The Lancet, and it is home to six federal research designations to develop cutting-edge solutions for patients. Biologics Lab and Aphasia Research Integration: We have integrated our biologics laboratory with the rest of the hospital in the aphasia research program. We are now genetically sequencing patients in the stroke rehabilitation program to understand the genetic basis (if any) for response to therapy. This work was funded by NIDILRR. The NIDILRR-funded center is especially for patients with hemispheric stroke - the most debilitating kind. Initial results have demonstrated a biological basis for response to therapy. Based on new studies from adult stem cells in patients with cerebral palsy (CP), we have begun the first-of-its-kind drug repurposing study in these patients in an attempt to relieve painful and disfiguring muscle contractures. Manipulation and Mobility Technologies: A NIDILRR-funded Rehabilitation Engineering Research Center award to fund six new projects researching innovations that are directly useful for patients, especially those who have experienced limb-loss or stroke. Projects include body-powered hand prostheses, use of powered exoskeleton for after-stroke patients, and a new wheelchair to allow both sitting and standing. Research will include both technology development and clinical testing. Health and Function in Physical Disability: This Rehabilitation and Training Center, funded by NIDILRR, was created to develop, evaluate, and implement methods to promote optimal health and function of people with physical disabilities. Through a variety of research, training and dissemination activities, we have begun to gain a more comprehensive understanding of the efficacy and value of various interventions for achieving and maintaining health and function for people with a disability. We have also created a mentoring program to encourage and train the next generation of rehabilitation researchers. Spinal Cord Injury Research: SRAlab operates the Midwest Regional Spinal Cord Injury Care System as designated by NIDILRR. One of only 14 SCI Model Systems nationwide, SRAlab advances spinal cord care through clinical research that identifies new standards of care for the industry. It leads multiple independent and collaborative research projects exploring walking therapy technologies that deliver the most effective treatment to advance ability. This year we completed the first part of a unique pharmacological treatment of chronic spinal cord injury as the only center in the world with this drug. Engineering Research: This project established a NIDILRR-funded Rehabilitation Engineering Research Center, Collaborative Machines Enhancing Therapies (COMET), focusing on advancing technologies that work in partnership with patients and clinicians to enhance gait and dexterity outcomes for individuals with stroke and spinal cord injury (SCI) and other people with disabilities in a real-life rehabilitation setting. This project is based at SRAlab and leads four other major research universities around the United States. Wearable and Mobile Sensors: This center continues the "Center for Smart Use of Technologies to Assess Real World Outcomes" known as (CSTAR). This center serves as a national resource for rehabilitation professionals attempting to measure patient function in objective manners outside of the traditional clinical environment. Our partnership allows us to leverage the collective experience of our clinicians, scientists, engineers, and patients to provide the expertise, instruction, and mentoring to support the smart use of technology. One especially gratifying result of this grant has been the "seeding" of research grants to young faculty at various universities around the country. In the past four years, having invested approximately $700k in pilot projects, our grantees have used the results of these pilot projects to successfully compete for over $7M in federal funding! Rapid Non-Invasive Screening for Covid-19: Controlling the spread of the COVID-19 pandemic largely depends on scaling up the testing infrastructure for identifying infected individuals. This project establishes a novel paradigm based on recording the physiological responses elicited by a short (~2 minutes) sequence of activities (i.e. "snapshot"), to detect symptoms associated with COVID-19. We are employing a novel body-conforming soft wearable sensor placed on the suprasternal notch to capture data on physical activity, cardio-respiratory function, and cough sounds. Early results, although preliminary, suggest that a sensor-based snapshot paradigm may be a promising approach for non-invasive and repeatable testing to alert individuals that need further screening.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>9883797</ExpenseAmt>
        <RevenueAmt>1901279</RevenueAmt>
        <Desc>Medical Education: The Department of Physical Medicine and Rehabilitation at Northwestern University's Feinberg School of Medicine (Dept of PM&amp;R) is housed within SRAlab, which has one of the largest and most highly respected residency programs in Physical Medicine and Rehabilitation in the country. Resident physicians spend three to four years rotating through the Dept of PM&amp;R, taught by SRAlab physicians who are experts in this specialty, In FY 2024 SRAlab trained 52 residents. The SRAlab medical education program also provides opportunities for fourth year medical students from Northwestern University Feinberg School of Medicine to rotate in a rehabilitation setting to gain experience with spinal cord injury, brain injury, amputee rehabilitation, cancer rehabilitation, medically complex rehabilitation, and pediatric rehabilitation. There are approximately 180 medical students from Northwestern that rotate with us and additional 50 medical students from other medical school nationally that rotate with us. Fellowships: SRAlab offers 5 physician sub-specialty fellowships, funded primarily by donations, in Sports Medicine, Pain Medicine, Pediatric Rehabilitation, Brain Injury Rehabilitation, and Spinal Cord Injury Rehabilitation. In FY 2024, 13 physician fellows were named at SRAlab, 2 in Spinal Cord Medicine, 4 in Sports Medicine, 3 in Pediatric Rehabilitation, 2 in Brain Injury Medicine, and 2 in Pain Medicine. SRAlab also supports residencies for therapists, nurses and other non-physicians. Prosthetics and Orthotics (P&amp;O) Residency: SRAlab's Prosthetics thotics Center has several prosthetics thotics residency positions which are highly sought after. In FY2024, there were five residency positions, three orthotic residencies and two prosthetic residencies, each lasting 12 months. The American Board for Certification in Orthotics, Prosthetics, and Pedorthics (ABC) and the National Commission on Orthotic and Prosthetic Education (NCOPE) are working together to implement a combined discipline exam and residency model, therefore Shirley Ryan AbilityLab is transitioning to a future state with four dual-discipline (orthotics &amp; prosthetics) residency positions, each lasting 24 months and each resident gaining 12 months of orthotics experience and 12 months of prosthetics experience. Through these training programs, P&amp;O residents are mentored by SRAlab's certified, licensed professionals and gain exposure to a variety of clinical presentations and pathologies, clinical evaluation, prescription recommendation, documentation, collaboration with the multidisciplinary rehabilitation team, and the actual fabrication of devices. Academy: Since 1954, the organization has offered continuing education programming to help healthcare professionals stay at the forefront of the field. Each year, more than 11,000 students participate in Academy programs, which are taught by interdisciplinary teams of our recognized PM&amp;R specialists and visiting experts from around the world. These programs cover the latest evidence-based rehabilitation interventions, assessments, and discoveries including new courses in Functional Neurologic Disorders, Cognition, Vision and Pediatric Rehabilitation. By incorporating flexible modalities such as on-site workshops, online webinars and courses, and outreach programs, the Academy seeks to bring the latest insights to healthcare professionals in a format that best meets their learning needs. In 2024, the Academy offered 12 courses and more than 190 webinars reaching attendees from all 50 states and 50 countries.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>6088841</ExpenseAmt>
        <RevenueAmt>694219</RevenueAmt>
        <Desc>SRAlab's Henry B. Betts LIFE Center is a virtual and multimedia education center providing patient education and consumer health information for patients, families, staff and the community. Everything in the collection relates in some way to people living with a wide range of cognitive and physical impairments, chronic conditions or diseases affecting function. The website enables individuals across the globe to have access to current, peer-reviewed patient education and consumer health resources with real-time updates, printing on demand and a dashboard to save favorite resources for easy access. Resources such as the LIFE Center help individuals, and their families navigate the intricacies of health care and minimize the complexity of relevant health information. Having access to information empowers people to partner with their health care team to make the best choices for themselves, their families and engage in life-long learning. The Center's resources are organized according to eight topic areas: Medical Information and Care, Caregiving and Equipment, Housing and Transportation, Education and Employment, Support and Wellness, Recreation and Leisure, Finance and Law and Inspiration and Hope. LIFE web traffic in FY 2024 averaged 14,712 page views per month, up from 13,023 page views per month in FY 2023, with 176,554 page views annually, up from 156,274 page views annually in FY 2023 from more than 188 countries. This past year, the highest international web activity occurred in the United Kingdom, Australia, India, Canada, Philippines, and Germany. In FY 2024, total outreach and service efforts apart from web activity was 7,683 person contacts served which includes programs, classes, special events, resource requests, teaching activities, peer mentoring events and tours for patients, families, staff and the community. Sports and Fitness Program: The SRAlab Adaptive Sports and Fitness Program provides wellness opportunities to people with physical disabilities through sports and recreation as well as an accessible Fitness Center. All services offered in the adaptive sports program, which marked its 43rd year in FY 2024, are free of charge. The fitness programs, which celebrated its 28th anniversary, provides access to a 1-on-1 functional fitness activities and group fitness classes that operate between 6:15 am and 7 pm five days per week for a nominal participation fee. The sports and fitness program is funded primarily by grants and generous community donations and is operated by twelve full time equivalent staff. Additionally, volunteers logged nearly 8000 hours in FY 2024. The Shirley Ryan Adaptive Sports and Fitness Program is considered a national leader in health promotion for people with disabilities. In FY 2024 we continued to expand programming developing new initiatives to promote wellness opportunities for persons living with disabilities. The sports program recorded over 5800 visits by 490 registered participants, and the fitness program continues to provide services virtually, as well as, in person recording 5,600 one-on-one visits by its 230 registered participants in addition to 5,339 class visits, classes are held in person and virtually. A separate program for youth, the Tengelsen Family Foundation Sports for Kids program, recorded 776 visits by 120 Chicago area children with disabilities. Adaptive Sports and Fitness programs continue to develop community partnerships and collaborations that open doors for people living with a disability to lead an active healthy lifestyle. Vocational Rehabilitation Program: Beginning a career or returning to work following an illness or injury is important to a patient's financial security and emotional well-being. It can contribute to the achievement of a productive, independent and fulfilling life. For more than 50 years, the SRAlab has been providing comprehensive vocational rehabilitation services tailored to meet the needs of each client. Services include initial assessment, vocational counseling and guidance, diagnostic evaluation, work trial assessments, job analysis, return-to-work evaluations, job placement, resume writing, job interview workshops and internship coordination. The SRAlab covers the cost of initial assessments, which are not covered by most third-party payers. Patients receive vocational services at nine SRAlab facilities or via telehealth, ensuring that employment assistance is closely tied to community reintegration. During FY 2024 the program served 1132 clients. In the last year, we placed 96 individuals in jobs. Assistive Technology Programs: The Technology Center and the Wheelchair &amp; Seating Center, comprise SRAlab's Assistive Technology Programs. In FY 2024, the Assistive Technology Programs served approximately 2,888 unique patients. The SRAlab Technology Center provides computer access training, smartphone/tablet access, augmentative communication evaluations/treatment, and electronic aids to daily living, including recommendations for home automation and modifications, for people with different or changing abilities. Occupational therapists and speech language pathologists evaluate and recommend equipment for each individual's needs. Through a lending library, or support from manufacturers facilitated by Technology Center staff, patients can try items before purchasing them or borrow them for short-term use due to changing needs. Staff members speak to universities, schools, organizations for people with disabilities, senior centers and the general public. We also provide continuing education lectures in assistive technology through assistive tech conferences and the SRALAB Academy. The center provides 1 to 2 home visits if the client can no longer come to SRALab following their evaluation. We have also integrated the use of telehealth appointments. Staff recommend applying for SRALab charity funds if Patient's insurance is maxed out. The Technology Center served a total of 1422 clients representing 567 inpatients, 393 Day Rehab clients, and 462 outpatients in the past fiscal year. Rehabilitation Engineering staff collaborate with other allied health clinicians to provide consultation, evaluation, and design of individual solutions to aid persons with different abilities to complete activities of daily living with increased independence at home, work, and in the community. Rehabilitation Engineering involves fabricating custom equipment and modifying commercially available equipment and objects to create unique, individualized solutions to help patients navigate obstacles encountered in daily life. SRAlab provides free care for services and products, and provides real-life design experience to students through Northwestern University's engineering design program. The Wheelchair &amp; Seating Center staff evaluate and make recommendations for complex wheelchairs and customized seating systems for patients with significant mobility and postural needs. This includes manual wheelchairs; powered wheelchairs; custom-made and customized seat and back cushions to relieve pressure, prevent pressure sores, and maintain posture; alternative drive controls like sip and puff and head array systems; that help clients maintain or increase their mobility and independence, at home, work, or in the community. During FY24 the Wheelchair &amp; Seating Center continued to use telehealth appointments to serve our patients that were unable to attend an in person appointment. We served a total of 1466 patients, including 824 inpatients and 642 outpatients this past fiscal year.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>6088841</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcRevenueAmt>694219</TotalOtherProgSrvcRevenueAmt>
      <TotalProgramServiceExpensesAmt>365203226</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="IRS990ScheduleC">true</LobbyingActivitiesInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="IRS990ScheduleD">true</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD">true</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd>false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="IRS990ScheduleF">true</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="IRS990ScheduleF">true</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="IRS990ScheduleG">true</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd referenceDocumentId="IRS990ScheduleH">true</OperateHospitalInd>
      <AuditedFinancialStmtAttInd referenceDocumentId="AuditedFinancialStatements">true</AuditedFinancialStmtAttInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="IRS990ScheduleJ">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd referenceDocumentId="IRS990ScheduleK1">true</TaxExemptBondsInd>
      <InvestTaxExemptBondsInd>false</InvestTaxExemptBondsInd>
      <EscrowAccountInd>false</EscrowAccountInd>
      <OnBehalfOfIssuerInd>false</OnBehalfOfIssuerInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="IRS990ScheduleL">true</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="IRS990ScheduleL">true</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="IRS990ScheduleM">true</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="IRS990ScheduleR">true</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="IRS990ScheduleR">true</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>true</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="IRS990ScheduleR">true</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>228</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>3240</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>true</UnrelatedBusIncmOverLimitInd>
      <Form990TFiledInd>true</Form990TFiledInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>true</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>true</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>true</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>18</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>16</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>true</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>true</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>true</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>true</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>true</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IN</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>Jonathan M Tingstad</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>3122381000</PhoneNum>
        <USAddress>
          <AddressLine1Txt>355 East Erie Street</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>Daniel D Dolan Jr</PersonNm>
        <TitleTxt>Vice Chairman</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>M Jude Reyes</PersonNm>
        <TitleTxt>Chairman</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Michael P Krasny</PersonNm>
        <TitleTxt>Vice Chairman</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Nancy E Paridy</PersonNm>
        <TitleTxt>President, Chief Administrative Officer</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>2115305</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>658952</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Pablo Celnik MD</PersonNm>
        <TitleTxt>Chief Executive Officer (Beginning 9/23/23)</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>727875</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>6955</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Peggy M Kirk</PersonNm>
        <TitleTxt>President, CEO (ending 1/1/2024)</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>2811044</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>1458082</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Thomas A Reynolds III</PersonNm>
        <TitleTxt>Vice Chairman</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Christopher Gust</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Dan K Webb</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>James H Litinsky</PersonNm>
        <TitleTxt>Director (ending 5/15/24)</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Linda S Wolf</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Mark F Stephan</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Michael L Keiser</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Richard B Murphy</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Robert O Delaney Jr</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Sharon L OKeefe</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Sheli Z Rosenberg</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Shirley W Ryan</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Wayne R Andersen</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>William E Lowry Jr</PersonNm>
        <TitleTxt>Director (ending 2/15/24)</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>William J Cernugel</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>1.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>1.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Jonathan M Tingstad</PersonNm>
        <TitleTxt>SVP, Chief Financial Officer</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>1102073</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>105934</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Laura L Ferrio</PersonNm>
        <TitleTxt>SVP, Chief Operating Officer</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>805159</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>78542</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>David J Weiss</PersonNm>
        <TitleTxt>Medical Director</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>709808</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>16502</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Elizabeth Owens</PersonNm>
        <TitleTxt>SVP, Chief Marketing and Innovation Officer</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>1197124</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>88084</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>James Sliwa DO</PersonNm>
        <TitleTxt>Chief Medical Officer</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>912488</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>67187</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Kelly Watkins</PersonNm>
        <TitleTxt>VP, Market Development</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>783303</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>200477</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Richard Lieber PhD</PersonNm>
        <TitleTxt>SVP of Research, Chief Scientific Officer</TitleTxt>
        <AverageHoursPerWeekRt>40.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>1205660</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>80818</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>12369839</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>2761533</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>339</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>CROTHALL FACILITIES MANAGEMENT</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>1500 LIBERTY RIDGE DR</AddressLine1Txt>
            <CityNm>WAYNE</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19087</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>Facility Care Services</ServicesDesc>
        <CompensationAmt>5436678</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>CERNER CORPORATION</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>PO BOX 959156</AddressLine1Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>631959156</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>IT Services</ServicesDesc>
        <CompensationAmt>5326764</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>CDW GOVERNMENT INC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>230 N MILWAUKEE AVE</AddressLine1Txt>
            <CityNm>VERNON HILLS</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60061</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>IT Services</ServicesDesc>
        <CompensationAmt>5297340</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>COLLABORATIVE SOLUTIONS LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>300 FRANK W BURR BLVD SUITE 36 6TH</AddressLine1Txt>
            <CityNm>TEANECK</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07666</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>IT Services</ServicesDesc>
        <CompensationAmt>3751257</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>MCGAW MEDICAL CENTER</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>NORTHWESTERN UNIVERSITY</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>606110402</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>Medical Services</ServicesDesc>
        <CompensationAmt>3476374</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>165</CntrctRcvdGreaterThan100KCnt>
      <FundraisingAmt>4858287</FundraisingAmt>
      <GovernmentGrantsAmt>21089339</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>31639277</AllOtherContributionsAmt>
      <NoncashContributionsAmt>800841</NoncashContributionsAmt>
      <TotalContributionsAmt>57586903</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>Net Patient Revenue</Desc>
        <BusinessCd>621990</BusinessCd>
        <TotalRevenueColumnAmt>332408985</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>332408985</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>Affiliation Income</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>15557083</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>9125961</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>6431122</UnrelatedBusinessRevenueAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>Sponsored Research Rev</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>10043480</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>10043480</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>Medicare GME Payment</Desc>
        <BusinessCd>622310</BusinessCd>
        <TotalRevenueColumnAmt>1148151</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1148151</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>Consulting</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>6726454</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5716683</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>1009771</UnrelatedBusinessRevenueAmt>
      </ProgramServiceRevenueGrp>
      <TotalOthProgramServiceRevGrp>
        <TotalRevenueColumnAmt>4355248</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>4355248</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>0</ExclusionAmt>
      </TotalOthProgramServiceRevGrp>
      <TotalProgramServiceRevenueAmt>370239401</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>5292058</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>270379</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>5021679</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>73110</TotalRevenueColumnAmt>
        <ExclusionAmt>73110</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <GrossRentsGrp>
        <RealAmt>233564</RealAmt>
      </GrossRentsGrp>
      <RentalIncomeOrLossGrp>
        <RealAmt>233564</RealAmt>
        <PersonalAmt>0</PersonalAmt>
      </RentalIncomeOrLossGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>233564</TotalRevenueColumnAmt>
        <ExclusionAmt>233564</ExclusionAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>219808580</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>209053022</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>10755558</SecuritiesAmt>
        <OtherAmt>0</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>10755558</TotalRevenueColumnAmt>
        <ExclusionAmt>10755558</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>263491</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>4858287</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>804881</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>-541390</TotalRevenueColumnAmt>
        <ExclusionAmt>-541390</ExclusionAmt>
      </NetIncmFromFundraisingEvtGrp>
      <OtherRevenueMiscGrp>
        <Desc>Parking</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1741894</TotalRevenueColumnAmt>
        <ExclusionAmt>1741894</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>Cafeteria Sales</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1350057</TotalRevenueColumnAmt>
        <ExclusionAmt>1350057</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <MiscellaneousRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>0</ExclusionAmt>
      </MiscellaneousRevenueGrp>
      <OtherRevenueTotalAmt>3091951</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>446731155</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>362798508</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>7711272</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>18634472</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>5805314</TotalAmt>
        <ProgramServicesAmt>5805314</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>534775</TotalAmt>
        <ProgramServicesAmt>534775</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>547690</TotalAmt>
        <ProgramServicesAmt>547690</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>8290294</TotalAmt>
        <ProgramServicesAmt>0</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8290294</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>77556</TotalAmt>
        <ProgramServicesAmt>77556</ProgramServicesAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>205608502</TotalAmt>
        <ProgramServicesAmt>188656437</ProgramServicesAmt>
        <ManagementAndGeneralAmt>15639819</ManagementAndGeneralAmt>
        <FundraisingAmt>1312246</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>13101859</TotalAmt>
        <ProgramServicesAmt>14724</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13087135</ManagementAndGeneralAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>24328367</TotalAmt>
        <ProgramServicesAmt>24158604</ProgramServicesAmt>
        <FundraisingAmt>169763</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>14254014</TotalAmt>
        <ProgramServicesAmt>12955630</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1216258</ManagementAndGeneralAmt>
        <FundraisingAmt>82126</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>4067819</TotalAmt>
        <ProgramServicesAmt>2866094</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1184957</ManagementAndGeneralAmt>
        <FundraisingAmt>16768</FundraisingAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>957014</TotalAmt>
        <ProgramServicesAmt>35660</ProgramServicesAmt>
        <ManagementAndGeneralAmt>921354</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>520465</TotalAmt>
        <ProgramServicesAmt>39425</ProgramServicesAmt>
        <ManagementAndGeneralAmt>481040</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>192750</TotalAmt>
        <ManagementAndGeneralAmt>192750</ManagementAndGeneralAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>90000</TotalAmt>
        <FundraisingAmt>90000</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>1091144</TotalAmt>
        <ProgramServicesAmt>584982</ProgramServicesAmt>
        <ManagementAndGeneralAmt>506162</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>26867261</TotalAmt>
        <ProgramServicesAmt>20125001</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6704489</ManagementAndGeneralAmt>
        <FundraisingAmt>37771</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>3129889</TotalAmt>
        <ProgramServicesAmt>2704854</ProgramServicesAmt>
        <ManagementAndGeneralAmt>394729</ManagementAndGeneralAmt>
        <FundraisingAmt>30306</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>9483204</TotalAmt>
        <ProgramServicesAmt>8231293</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1213443</ManagementAndGeneralAmt>
        <FundraisingAmt>38468</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>14677121</TotalAmt>
        <ProgramServicesAmt>13925788</ProgramServicesAmt>
        <ManagementAndGeneralAmt>693734</ManagementAndGeneralAmt>
        <FundraisingAmt>57599</FundraisingAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>8302873</TotalAmt>
        <ProgramServicesAmt>7309095</ProgramServicesAmt>
        <ManagementAndGeneralAmt>979992</ManagementAndGeneralAmt>
        <FundraisingAmt>13786</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>1994023</TotalAmt>
        <ProgramServicesAmt>1710170</ProgramServicesAmt>
        <ManagementAndGeneralAmt>259985</ManagementAndGeneralAmt>
        <FundraisingAmt>23868</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>955871</TotalAmt>
        <ProgramServicesAmt>809235</ProgramServicesAmt>
        <ManagementAndGeneralAmt>136601</ManagementAndGeneralAmt>
        <FundraisingAmt>10035</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>12523241</TotalAmt>
        <ProgramServicesAmt>10157329</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2328518</ManagementAndGeneralAmt>
        <FundraisingAmt>37394</FundraisingAmt>
      </InterestGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>28300822</TotalAmt>
        <ProgramServicesAmt>24415801</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3820086</ManagementAndGeneralAmt>
        <FundraisingAmt>64935</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>3642568</TotalAmt>
        <ManagementAndGeneralAmt>3642568</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>Medical Supplies</Desc>
        <TotalAmt>19201008</TotalAmt>
        <ProgramServicesAmt>19095658</ProgramServicesAmt>
        <ManagementAndGeneralAmt>103628</ManagementAndGeneralAmt>
        <FundraisingAmt>1722</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Medicaid Provider Tax</Desc>
        <TotalAmt>11582433</TotalAmt>
        <ProgramServicesAmt>11582433</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Contract Labor</Desc>
        <TotalAmt>3785759</TotalAmt>
        <ProgramServicesAmt>2824387</ProgramServicesAmt>
        <ManagementAndGeneralAmt>960667</ManagementAndGeneralAmt>
        <FundraisingAmt>705</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Real Estate Taxes</Desc>
        <TotalAmt>1471507</TotalAmt>
        <ProgramServicesAmt>1471507</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>6036362</TotalAmt>
        <ProgramServicesAmt>4563784</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1375530</ManagementAndGeneralAmt>
        <FundraisingAmt>97048</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>431421505</TotalAmt>
        <ProgramServicesAmt>365203226</ProgramServicesAmt>
        <ManagementAndGeneralAmt>64133739</ManagementAndGeneralAmt>
        <FundraisingAmt>2084540</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1621735</BOYAmt>
        <EOYAmt>827614</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>8088853</BOYAmt>
        <EOYAmt>8820969</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>39749622</BOYAmt>
        <EOYAmt>43405539</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>32341388</BOYAmt>
        <EOYAmt>41013363</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>2492042</BOYAmt>
        <EOYAmt>2467317</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>4766849</BOYAmt>
        <EOYAmt>3775899</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>748262110</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>223273104</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>540729973</BOYAmt>
        <EOYAmt>524989006</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>205354779</BOYAmt>
        <EOYAmt>257840783</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>312241192</BOYAmt>
        <EOYAmt>346262443</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <BOYAmt>13172074</BOYAmt>
        <EOYAmt>12543090</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>19458707</BOYAmt>
        <EOYAmt>25000884</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>1180017214</BOYAmt>
        <EOYAmt>1266946907</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>40846770</BOYAmt>
        <EOYAmt>49166482</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>6284722</BOYAmt>
        <EOYAmt>8128901</EOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>9365005</BOYAmt>
        <EOYAmt>10685481</EOYAmt>
      </DeferredRevenueGrp>
      <TaxExemptBondLiabilitiesGrp>
        <BOYAmt>281938420</BOYAmt>
        <EOYAmt>264302862</EOYAmt>
      </TaxExemptBondLiabilitiesGrp>
      <LoansFromOfficersDirectorsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </LoansFromOfficersDirectorsGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>77877600</BOYAmt>
        <EOYAmt>75021160</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>416312517</BOYAmt>
        <EOYAmt>407304886</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>563947700</BOYAmt>
        <EOYAmt>637175489</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>199756997</BOYAmt>
        <EOYAmt>222466532</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>763704697</BOYAmt>
        <EOYAmt>859642021</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>1180017214</BOYAmt>
        <EOYAmt>1266946907</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>15309650</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>69547723</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>11079951</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>true</FederalGrantAuditRequiredInd>
      <FederalGrantAuditPerformedInd>true</FederalGrantAuditPerformedInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA" softwareId="23017437" softwareVersionNum="2023v6.0">
      <HospitalInd>X</HospitalInd>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="23017437" softwareVersionNum="2023v6.0">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="IRS990ScheduleC" softwareId="23017437" softwareVersionNum="2023v6.0">
      <VolunteersInd>false</VolunteersInd>
      <PaidStaffOrManagementInd>false</PaidStaffOrManagementInd>
      <MediaAdvertisementsInd>false</MediaAdvertisementsInd>
      <MailingsMembersInd>false</MailingsMembersInd>
      <PublicationsOrBroadcastInd>false</PublicationsOrBroadcastInd>
      <GrantsOtherOrganizationsInd>false</GrantsOtherOrganizationsInd>
      <DirectContactLegislatorsInd>false</DirectContactLegislatorsInd>
      <RalliesDemonstrationsInd>false</RalliesDemonstrationsInd>
      <OtherActivitiesInd>true</OtherActivitiesInd>
      <OtherActivitiesAmt>217218</OtherActivitiesAmt>
      <TotalLobbyingExpendituresAmt>217218</TotalLobbyingExpendituresAmt>
      <NotDescribedSection501c3Ind>false</NotDescribedSection501c3Ind>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITY</FormAndLineReferenceDesc>
        <ExplanationTxt>SRALAB LOBBIES FEDERAL AND STATE GOVERNMENT ON ISSUES RELATED TO HEALTHCARE PROVIDER ISSUES, INCLUDING BUT NOT LIMITED TO MEDICARE, MEDICAID AND OTHER GOVERNMENT HEALTH CARE PROGRAMS, AS WELL AS OTHER REHABILITATION FOCUSED ISSUES. Total LOBBYING EXPENSES were $217,218. THE MAJORITY OF LOBBYING EXPENSES ($192,750) ARE PAID TO THIRD PARTY LOBBYING FIRMS. ADDITIONALLY, A PERCENTAGE OF THE TOTAL DUES FOR THE ILLINOIS HOSPITAL ASSOCIATION (37% IN CALENDAR YEAR 2023 &amp; 43.5% IN CALENDAR YEAR 2024) GOES TOWARD LOBBYING EFFORTS, WHICH AMOUNTS TO $18,154. SRALAB DOES NOT PARTICIPATE IN OR INTERVENE IN (INCLUDING THE PUBLISHING OR DISTRIBUTING OF STATEMENTS) ANY POLITICAL CAMPAIGN ON BEHALF OF (OR IN OPPOSITION TO) ANY CANDIDATE FOR PUBLIC OFFICE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="IRS990ScheduleD" softwareId="23017437" softwareVersionNum="2023v6.0">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>112034411</BeginningYearBalanceAmt>
        <ContributionsAmt>5005000</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>20628479</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>5279151</OtherExpendituresAmt>
        <EndYearBalanceAmt>132388739</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>106818946</BeginningYearBalanceAmt>
        <ContributionsAmt>0</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>10358572</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>5143107</OtherExpendituresAmt>
        <EndYearBalanceAmt>112034411</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>131142076</BeginningYearBalanceAmt>
        <ContributionsAmt>1501050</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-20696834</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>5127346</OtherExpendituresAmt>
        <EndYearBalanceAmt>106818946</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>109390922</BeginningYearBalanceAmt>
        <ContributionsAmt>5881</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>26426874</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>4681601</OtherExpendituresAmt>
        <EndYearBalanceAmt>131142076</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>103561767</BeginningYearBalanceAmt>
        <ContributionsAmt>11061</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>10290557</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>4472463</OtherExpendituresAmt>
        <EndYearBalanceAmt>109390922</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.0391</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.4713</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.4896</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>false</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>false</EndowmentsHeldRelatedOrgInd>
      <LandGrp>
        <OtherCostOrOtherBasisAmt>32333426</OtherCostOrOtherBasisAmt>
        <BookValueAmt>32333426</BookValueAmt>
      </LandGrp>
      <BuildingsGrp>
        <OtherCostOrOtherBasisAmt>546557278</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>114532132</DepreciationAmt>
        <BookValueAmt>432025146</BookValueAmt>
      </BuildingsGrp>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>27376315</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>15382395</DepreciationAmt>
        <BookValueAmt>11993920</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>137029571</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>93358577</DepreciationAmt>
        <BookValueAmt>43670994</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>4965520</OtherCostOrOtherBasisAmt>
        <BookValueAmt>4965520</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>524989006</TotalBookValueLandBuildingsAmt>
      <OtherSecuritiesGrp>
        <Desc>Cash and Cash Equivalents</Desc>
        <BookValueAmt>45553149</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>Absolute Return</Desc>
        <BookValueAmt>49135931</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>Hedged Equity</Desc>
        <BookValueAmt>52223831</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>International Equity</Desc>
        <BookValueAmt>52066083</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>International Hedged Equity</Desc>
        <BookValueAmt>62107348</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>Pvt Equity, Real Assets &amp; Contracts</Desc>
        <BookValueAmt>85176101</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <TotalBookValueSecuritiesAmt>346262443</TotalBookValueSecuritiesAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>Self-Insurance Reserves</Desc>
        <Amt>8593358</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Estimated Third Party Settlements Payable</Desc>
        <Amt>21331743</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Due to Affiliates (Pathways)</Desc>
        <Amt>866000</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Accrued Pension</Desc>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>457 Plan Liability</Desc>
        <Amt>22575247</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>SWAP Liability</Desc>
        <Amt>3602769</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Bond Issuance Fee + Annuity Liability</Desc>
        <Amt>54510</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Lease Liability</Desc>
        <Amt>17717202</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Medicare Advance</Desc>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Capital Lease Liability - LT</Desc>
        <Amt>280331</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Cloud Computing Contract Payable - LT</Desc>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>LT DEFERRED FICA</Desc>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>75021160</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule D, Part VI, Line 1c</FormAndLineReferenceDesc>
        <ExplanationTxt>Depreciation for leasehold improvements is included in the same general ledger account as building depreciation. There is related depreciation for leasehold improvements, but it cannot be bifurcated for Form 990 purposes.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule D, Part V, Line 4 Intended uses of endowment funds</FormAndLineReferenceDesc>
        <ExplanationTxt>The intended use for each of the SRAlab endowment funds is established by the donor. The majority of the endowment funds are used to support medical education, clinical care, free care, research, medical leadership, fellowships, and the SRAlab Academy.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote</FormAndLineReferenceDesc>
        <ExplanationTxt>RII, the Shirley Ryan AbilityLab, and Pathways are not-for-profit corporations as described in Section 501(c)(3) of the Internal Revenue Code (the "Code") and are exempt from federal income taxes on related income pursuant to Section 501(a) of the Code. Despite the general exemption from income taxes, RII and the Shirley Ryan AbilityLab are subject to federal and state income taxes at corporate rates on unrelated business income. Included in the consolidated statements of operations and changes in net assets is the provision for current taxes of $1,329,000 and $678,000 for the years ended August 31, 2024 and 2023, respectively. The corporations do not have any material tax positions as of August 31, 2024 and 2023.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="IRS990ScheduleF" softwareId="23017437" softwareVersionNum="2023v6.0">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Conference Travel</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Travel related to clinical care, education and training, Research and business development.</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>160137</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>North America (Canada &amp; Mexico only)</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Conference Travel</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Travel related to clinical care, education and training, Research and business development.</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>15122</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Conference Travel</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Travel related to clinical care, education and training, Research and business development.</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>68733</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Grantmaking</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Payments to Research related Subcontractors</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>370418</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Middle East and North Africa</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Conference Travel</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Travel related to clinical care, education and training, Research and business development.</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>436849</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>North America (Canada &amp; Mexico only)</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Grantmaking</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Payments to Research related Subcontractors</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>133165</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Grantmaking</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Payments to Research related Subcontractors</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>44107</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>South Asia</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services,Conference Travel</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Travel related to clinical care, education and training, Research and business development.</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>21029</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>1249560</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>1249560</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>44107</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America (Canada &amp; Mexico only)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>39129</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America (Canada &amp; Mexico only)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>74870</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America (Canada &amp; Mexico only)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>3395</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America (Canada &amp; Mexico only)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>15771</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>129261</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>170614</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>38024</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>23859</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
        <CashGrantAmt>8660</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Wire Transfer</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>0</Total501c3OrgCnt>
      <TotalOtherOrgCnt>10</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>true</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>false</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>true</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>true</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>true</ForeignPartnershipInd>
      <BoycottCountriesInd>true</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds</FormAndLineReferenceDesc>
        <ExplanationTxt>Each research grant is assigned a Principal Investigator (PI) as well as a Research Administrator (RA). Grant expenditures charged to each grant are approved/reviewed by the respective PI and or RA to ensure allowability. In addition, compliance (A-133) audits are performed by an independent audit firm each year. Program services as detailed in Schedule F, Part I, are derived from our Global Services and other foreign designated cost centers. SRALab credit cards were also reviewed for foreign transactions, and where applicable, those transactions were included.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements</FormAndLineReferenceDesc>
        <ExplanationTxt>EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA &amp; MEXICO ONLY)-Accrual; SOUTH ASIA-Accrual</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule F, Part II, Line 1 Method used to account for expenditures on org's financial statements</FormAndLineReferenceDesc>
        <ExplanationTxt>EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA &amp; MEXICO ONLY)-Accrual</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="IRS990ScheduleG" softwareId="23017437" softwareVersionNum="2023v6.0">
      <MailSolicitationsInd>X</MailSolicitationsInd>
      <EmailSolicitationsInd>X</EmailSolicitationsInd>
      <PhoneSolicitationsInd>X</PhoneSolicitationsInd>
      <InPersonSolicitationsInd>X</InPersonSolicitationsInd>
      <SolicitationOfNonGovtGrantsInd>X</SolicitationOfNonGovtGrantsInd>
      <SolicitationOfGovtGrantsInd>X</SolicitationOfGovtGrantsInd>
      <SpecialFundraisingEventsInd>X</SpecialFundraisingEventsInd>
      <AgrmtProfFundraisingActyInd>true</AgrmtProfFundraisingActyInd>
      <FundraiserActivityInfoGrp>
        <OrganizationBusinessName>
          <BusinessNameLine1Txt>PJH &amp; associates Inc</BusinessNameLine1Txt>
        </OrganizationBusinessName>
        <USAddress>
          <AddressLine1Txt>205 West Wacker Drive</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60606</ZIPCd>
        </USAddress>
        <ActivityTxt>Advisory Services for Event Giving</ActivityTxt>
        <FundraiserControlOfFundsInd>false</FundraiserControlOfFundsInd>
        <GrossReceiptsAmt>193244</GrossReceiptsAmt>
        <RetainedByContractorAmt>90000</RetainedByContractorAmt>
        <NetToOrganizationAmt>103244</NetToOrganizationAmt>
      </FundraiserActivityInfoGrp>
      <TotalGrossReceiptsAmt>193244</TotalGrossReceiptsAmt>
      <TotalRetainedByContractorsAmt>90000</TotalRetainedByContractorsAmt>
      <TotalNetToOrganizationAmt>103244</TotalNetToOrganizationAmt>
      <LicensedStatesCd>AL</LicensedStatesCd>
      <LicensedStatesCd>AK</LicensedStatesCd>
      <LicensedStatesCd>AZ</LicensedStatesCd>
      <LicensedStatesCd>AR</LicensedStatesCd>
      <LicensedStatesCd>CA</LicensedStatesCd>
      <LicensedStatesCd>CO</LicensedStatesCd>
      <LicensedStatesCd>CT</LicensedStatesCd>
      <LicensedStatesCd>DE</LicensedStatesCd>
      <LicensedStatesCd>FL</LicensedStatesCd>
      <LicensedStatesCd>GA</LicensedStatesCd>
      <LicensedStatesCd>HI</LicensedStatesCd>
      <LicensedStatesCd>ID</LicensedStatesCd>
      <LicensedStatesCd>IL</LicensedStatesCd>
      <LicensedStatesCd>IN</LicensedStatesCd>
      <LicensedStatesCd>IA</LicensedStatesCd>
      <LicensedStatesCd>KS</LicensedStatesCd>
      <LicensedStatesCd>KY</LicensedStatesCd>
      <LicensedStatesCd>LA</LicensedStatesCd>
      <LicensedStatesCd>ME</LicensedStatesCd>
      <LicensedStatesCd>MD</LicensedStatesCd>
      <LicensedStatesCd>MA</LicensedStatesCd>
      <LicensedStatesCd>MI</LicensedStatesCd>
      <LicensedStatesCd>MN</LicensedStatesCd>
      <LicensedStatesCd>MS</LicensedStatesCd>
      <LicensedStatesCd>MO</LicensedStatesCd>
      <LicensedStatesCd>MT</LicensedStatesCd>
      <LicensedStatesCd>NE</LicensedStatesCd>
      <LicensedStatesCd>NV</LicensedStatesCd>
      <LicensedStatesCd>NH</LicensedStatesCd>
      <LicensedStatesCd>NJ</LicensedStatesCd>
      <LicensedStatesCd>NM</LicensedStatesCd>
      <LicensedStatesCd>NY</LicensedStatesCd>
      <LicensedStatesCd>NC</LicensedStatesCd>
      <LicensedStatesCd>ND</LicensedStatesCd>
      <LicensedStatesCd>OH</LicensedStatesCd>
      <LicensedStatesCd>OK</LicensedStatesCd>
      <LicensedStatesCd>OR</LicensedStatesCd>
      <LicensedStatesCd>PA</LicensedStatesCd>
      <LicensedStatesCd>RI</LicensedStatesCd>
      <LicensedStatesCd>SC</LicensedStatesCd>
      <LicensedStatesCd>SD</LicensedStatesCd>
      <LicensedStatesCd>TN</LicensedStatesCd>
      <LicensedStatesCd>TX</LicensedStatesCd>
      <LicensedStatesCd>UT</LicensedStatesCd>
      <LicensedStatesCd>VT</LicensedStatesCd>
      <LicensedStatesCd>VA</LicensedStatesCd>
      <LicensedStatesCd>WA</LicensedStatesCd>
      <LicensedStatesCd>WV</LicensedStatesCd>
      <LicensedStatesCd>WI</LicensedStatesCd>
      <LicensedStatesCd>WY</LicensedStatesCd>
      <FundraisingEventInformationGrp>
        <Event1Nm>Spark! Signature Event</Event1Nm>
        <GrossReceiptsEvent1Amt>3864885</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>3724600</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>140285</GrossRevenueEvent1Amt>
        <RentFacilityCostsEvent1Amt>9350</RentFacilityCostsEvent1Amt>
        <FoodAndBeverageEvent1Amt>127756</FoodAndBeverageEvent1Amt>
        <EntertainmentEvent1Amt>166200</EntertainmentEvent1Amt>
        <OtherDirectExpensesEvent1Amt>340759</OtherDirectExpensesEvent1Amt>
        <Event2Nm>SkyRise</Event2Nm>
        <GrossReceiptsEvent2Amt>825697</GrossReceiptsEvent2Amt>
        <CharitableContriEvent2Amt>765989</CharitableContriEvent2Amt>
        <GrossRevenueEvent2Amt>59708</GrossRevenueEvent2Amt>
        <OtherDirectExpensesEvent2Amt>115217</OtherDirectExpensesEvent2Amt>
        <OtherEventsTotalCnt>2</OtherEventsTotalCnt>
        <GrossReceiptsOtherEventsAmt>431195</GrossReceiptsOtherEventsAmt>
        <CharitableContriOtherEventsAmt>367697</CharitableContriOtherEventsAmt>
        <GrossRevenueOtherEventsAmt>63498</GrossRevenueOtherEventsAmt>
        <RentFcltyCostsOtherEventsAmt>6400</RentFcltyCostsOtherEventsAmt>
        <FoodAndBeverageOtherEventsAmt>16949</FoodAndBeverageOtherEventsAmt>
        <EntertainmentOtherEventsAmt>351</EntertainmentOtherEventsAmt>
        <OthDirectExpnssOtherEventsAmt>21899</OthDirectExpnssOtherEventsAmt>
        <GrossReceiptsTotalAmt>5121777</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>4858286</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>263491</GrossRevenueTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>15750</RentFcltyCostsTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>144705</FoodAndBeverageTotalEventsAmt>
        <EntertainmentTotalEventsAmt>166551</EntertainmentTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>477875</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>804881</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>-541390</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleH documentId="IRS990ScheduleH" softwareId="23017437" softwareVersionNum="2023v6.0">
      <FinancialAssistancePolicyInd>true</FinancialAssistancePolicyInd>
      <WrittenPolicyInd>true</WrittenPolicyInd>
      <AllHospitalsPolicyInd>X</AllHospitalsPolicyInd>
      <FPGReferenceFreeCareInd>true</FPGReferenceFreeCareInd>
      <FreeCareOthPercentageGrp>
        <OtherInd>X</OtherInd>
        <FreeCareOtherPct>250</FreeCareOtherPct>
      </FreeCareOthPercentageGrp>
      <FPGReferenceDiscountedCareInd>true</FPGReferenceDiscountedCareInd>
      <DiscountedCareOthPercentageGrp>
        <OtherInd>X</OtherInd>
        <DiscountedCareOtherPct>600</DiscountedCareOtherPct>
      </DiscountedCareOthPercentageGrp>
      <FreeCareMedicallyIndigentInd>true</FreeCareMedicallyIndigentInd>
      <FinancialAssistanceBudgetInd>true</FinancialAssistanceBudgetInd>
      <ExpensesExceedBudgetInd>false</ExpensesExceedBudgetInd>
      <AnnualCommunityBnftReportInd>true</AnnualCommunityBnftReportInd>
      <ReportPublicallyAvailableInd>true</ReportPublicallyAvailableInd>
      <FinancialAssistanceAtCostTyp>
        <TotalCommunityBenefitExpnsAmt>142023</TotalCommunityBenefitExpnsAmt>
        <NetCommunityBenefitExpnsAmt>142023</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0003</TotalExpensePct>
      </FinancialAssistanceAtCostTyp>
      <UnreimbursedMedicaidGrp>
        <TotalCommunityBenefitExpnsAmt>59925760</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>43889148</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>16036612</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0372</TotalExpensePct>
      </UnreimbursedMedicaidGrp>
      <UnreimbursedCostsGrp>
        <TotalCommunityBenefitExpnsAmt>904623</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>0</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>904623</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0021</TotalExpensePct>
      </UnreimbursedCostsGrp>
      <TotalFinancialAssistanceTyp>
        <ActivitiesOrProgramsCnt>0</ActivitiesOrProgramsCnt>
        <PersonsServedCnt>0</PersonsServedCnt>
        <TotalCommunityBenefitExpnsAmt>60972406</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>43889148</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>17083258</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0396</TotalExpensePct>
      </TotalFinancialAssistanceTyp>
      <CommunityHealthServicesGrp>
        <TotalCommunityBenefitExpnsAmt>6486443</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>505248</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>5981195</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0139</TotalExpensePct>
      </CommunityHealthServicesGrp>
      <HealthProfessionsEducationGrp>
        <TotalCommunityBenefitExpnsAmt>9883797</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>1901279</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>7982518</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0185</TotalExpensePct>
      </HealthProfessionsEducationGrp>
      <SubsidizedHealthServicesGrp>
        <TotalCommunityBenefitExpnsAmt>718238</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>377377</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>340861</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0008</TotalExpensePct>
      </SubsidizedHealthServicesGrp>
      <ResearchGrp>
        <TotalCommunityBenefitExpnsAmt>49742406</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>36527398</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>13215008</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0306</TotalExpensePct>
      </ResearchGrp>
      <CashAndInKindContributionsGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </CashAndInKindContributionsGrp>
      <TotalOtherBenefitsGrp>
        <ActivitiesOrProgramsCnt>0</ActivitiesOrProgramsCnt>
        <PersonsServedCnt>0</PersonsServedCnt>
        <TotalCommunityBenefitExpnsAmt>66830884</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>39311302</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>27519582</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0638</TotalExpensePct>
      </TotalOtherBenefitsGrp>
      <TotalCommunityBenefitsGrp>
        <ActivitiesOrProgramsCnt>0</ActivitiesOrProgramsCnt>
        <PersonsServedCnt>0</PersonsServedCnt>
        <TotalCommunityBenefitExpnsAmt>127803290</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>83200450</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>44602840</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.1034</TotalExpensePct>
      </TotalCommunityBenefitsGrp>
      <PhysicalImprvAndHousingGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </PhysicalImprvAndHousingGrp>
      <EconomicDevelopmentGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </EconomicDevelopmentGrp>
      <CommunitySupportGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </CommunitySupportGrp>
      <EnvironmentalImprovementsGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </EnvironmentalImprovementsGrp>
      <LeadershipDevelopmentGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </LeadershipDevelopmentGrp>
      <CoalitionBuildingGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </CoalitionBuildingGrp>
      <HealthImprovementAdvocacyGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </HealthImprovementAdvocacyGrp>
      <WorkforceDevelopmentGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </WorkforceDevelopmentGrp>
      <OtherCommuntityBuildingActyGrp>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </OtherCommuntityBuildingActyGrp>
      <TotalCommuntityBuildingActyGrp>
        <ActivitiesOrProgramsCnt>0</ActivitiesOrProgramsCnt>
        <PersonsServedCnt>0</PersonsServedCnt>
        <TotalCommunityBenefitExpnsAmt>0</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>0</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>0</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.0</TotalExpensePct>
      </TotalCommuntityBuildingActyGrp>
      <BadDebtExpenseReportedInd>true</BadDebtExpenseReportedInd>
      <BadDebtExpenseAmt>0</BadDebtExpenseAmt>
      <BadDebtExpenseAttributableAmt>0</BadDebtExpenseAttributableAmt>
      <ReimbursedByMedicareAmt>49392832</ReimbursedByMedicareAmt>
      <CostOfCareReimbursedByMedcrAmt>70247413</CostOfCareReimbursedByMedcrAmt>
      <MedicareSurplusOrShortfallAmt>-20854581</MedicareSurplusOrShortfallAmt>
      <CostingMethodologyUsedGrp>
        <CostToChargeRatioInd>X</CostToChargeRatioInd>
      </CostingMethodologyUsedGrp>
      <WrittenDebtCollectionPolicyInd>true</WrittenDebtCollectionPolicyInd>
      <FinancialAssistancePrvsnInd>true</FinancialAssistancePrvsnInd>
      <HospitalFacilitiesCnt>1</HospitalFacilitiesCnt>
      <HospitalFacilitiesGrp>
        <FacilityNum>1</FacilityNum>
        <BusinessName>
          <BusinessNameLine1Txt>Shirley Ryan AbilityLab</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>355 East Erie Street</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <WebsiteAddressTxt>www.sralab.org</WebsiteAddressTxt>
        <StateLicenseNum>0001958</StateLicenseNum>
        <LicensedHospitalInd>X</LicensedHospitalInd>
        <TeachingHospitalInd>X</TeachingHospitalInd>
        <ResearchFacilityInd>X</ResearchFacilityInd>
        <OtherDesc>Physical Rehabilitation</OtherDesc>
      </HospitalFacilitiesGrp>
      <HospitalFcltyPoliciesPrctcGrp>
        <HospitalFacilityName>
          <BusinessNameLine1Txt>Shirley Ryan AbilityLab</BusinessNameLine1Txt>
        </HospitalFacilityName>
        <FacilityNum>1</FacilityNum>
        <FirstLicensedCYOrPYInd>false</FirstLicensedCYOrPYInd>
        <TaxExemptHospitalCYOrPYInd>false</TaxExemptHospitalCYOrPYInd>
        <CHNAConductedInd>true</CHNAConductedInd>
        <CommunityDefinitionInd>X</CommunityDefinitionInd>
        <CommunityDemographicsInd>X</CommunityDemographicsInd>
        <ExistingResourcesInd>X</ExistingResourcesInd>
        <HowDataObtainedInd>X</HowDataObtainedInd>
        <CommunityHealthNeedsInd>X</CommunityHealthNeedsInd>
        <OtherHealthIssuesInd>X</OtherHealthIssuesInd>
        <CommunityHlthNeedsIdProcessInd>X</CommunityHlthNeedsIdProcessInd>
        <ConsultingProcessInd>X</ConsultingProcessInd>
        <PriorCHNAImpactInd>X</PriorCHNAImpactInd>
        <CHNAConductedYr>21</CHNAConductedYr>
        <TakeIntoAccountOthersInputInd>true</TakeIntoAccountOthersInputInd>
        <CHNAConductedWithOtherFcltsInd>false</CHNAConductedWithOtherFcltsInd>
        <CHNAConductedWithNonFcltsInd>false</CHNAConductedWithNonFcltsInd>
        <CHNAReportWidelyAvailableInd>true</CHNAReportWidelyAvailableInd>
        <RptAvailableOnOwnWebsiteInd>X</RptAvailableOnOwnWebsiteInd>
        <OwnWebsiteURLTxt>https://www.sralab.org/community-health-needs-assessment</OwnWebsiteURLTxt>
        <PaperCopyPublicInspectionInd>X</PaperCopyPublicInspectionInd>
        <ImplementationStrategyAdoptInd>true</ImplementationStrategyAdoptInd>
        <ImplementationStrategyAdptYr>22</ImplementationStrategyAdptYr>
        <StrategyPostedWebsiteInd>true</StrategyPostedWebsiteInd>
        <StrategyWebsiteURLTxt>https://www.sralab.org/community-health-needs-assessment</StrategyWebsiteURLTxt>
        <OrganizationIncurExciseTaxInd>false</OrganizationIncurExciseTaxInd>
        <EligCriteriaExplainedInd>true</EligCriteriaExplainedInd>
        <FPGFamilyIncmLmtFreeDscntInd>X</FPGFamilyIncmLmtFreeDscntInd>
        <FPGFamilyIncmLmtFreeCarePct>250.0</FPGFamilyIncmLmtFreeCarePct>
        <FPGFamilyIncmLmtDscntCarePct>600.0</FPGFamilyIncmLmtDscntCarePct>
        <AssetLevelCriteriaInd>X</AssetLevelCriteriaInd>
        <MedicalIndigencyCriteriaInd>X</MedicalIndigencyCriteriaInd>
        <InsuranceStatusCriteriaInd>X</InsuranceStatusCriteriaInd>
        <UnderinsuranceStatCriteriaInd>X</UnderinsuranceStatCriteriaInd>
        <ResidencyCriteriaInd>X</ResidencyCriteriaInd>
        <ExplainedBasisInd>true</ExplainedBasisInd>
        <AppFinancialAsstExplnInd>true</AppFinancialAsstExplnInd>
        <DescribedInfoInd>X</DescribedInfoInd>
        <DescribedSuprtDocInd>X</DescribedSuprtDocInd>
        <ProvidedHospitalContactInd>X</ProvidedHospitalContactInd>
        <IncludesPublicityMeasuresInd>true</IncludesPublicityMeasuresInd>
        <FAPAvailableOnWebsiteInd>X</FAPAvailableOnWebsiteInd>
        <FAPAvailableOnWebsiteURLTxt>https://www.sralab.org/charity-care-financial-assistance</FAPAvailableOnWebsiteURLTxt>
        <FAPAppAvailableOnWebsiteInd>X</FAPAppAvailableOnWebsiteInd>
        <FAPAppAvailableOnWebsiteURLTxt>https://www.sralab.org/charity-care-financial-assistance</FAPAppAvailableOnWebsiteURLTxt>
        <FAPSummaryOnWebsiteInd>X</FAPSummaryOnWebsiteInd>
        <FAPSummaryOnWebsiteURLTxt>https://www.sralab.org/charity-care-financial-assistance</FAPSummaryOnWebsiteURLTxt>
        <FAPAvlblOnRequestNoChargeInd>X</FAPAvlblOnRequestNoChargeInd>
        <FAPAppAvlblOnRequestNoChrgInd>X</FAPAppAvlblOnRequestNoChrgInd>
        <FAPSumAvlblOnRequestNoChrgInd>X</FAPSumAvlblOnRequestNoChrgInd>
        <NotifiedFAPCopyBillDisplayInd>X</NotifiedFAPCopyBillDisplayInd>
        <CommuntityNotifiedFAPInd>X</CommuntityNotifiedFAPInd>
        <FAPTranslatedInd>X</FAPTranslatedInd>
        <OtherPublicityInd>X</OtherPublicityInd>
        <FAPActionsOnNonpaymentInd>true</FAPActionsOnNonpaymentInd>
        <PermitNoActionsInd>X</PermitNoActionsInd>
        <CollectionActivitiesInd>false</CollectionActivitiesInd>
        <ProvidedWrittenNoticeInd>X</ProvidedWrittenNoticeInd>
        <MadeEffortOrallyNotifyInd>X</MadeEffortOrallyNotifyInd>
        <ProcessedFAPApplicationInd>X</ProcessedFAPApplicationInd>
        <MadePresumptiveEligDetermInd>X</MadePresumptiveEligDetermInd>
        <NondisEmergencyCarePolicyInd>true</NondisEmergencyCarePolicyInd>
        <LookBackMedicarePrivateInd>X</LookBackMedicarePrivateInd>
        <AmountsGenerallyBilledInd>false</AmountsGenerallyBilledInd>
        <GrossChargesInd>false</GrossChargesInd>
      </HospitalFcltyPoliciesPrctcGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>Schedule H, Part V, Section B, Line 3E</FormAndLineReferenceDesc>
        <ExplanationTxt>Yes, the significant health needs are a prioritized focus by the organization which is identified through the CHNA assessment and program.</ExplanationTxt>
      </SupplementalInformationGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>Schedule H, Part V, Section B, Line 5 Facility , 1</FormAndLineReferenceDesc>
        <ExplanationTxt>Facility , 1 - Shirley Ryan AbilityLab. Shirley Ryan AbilityLab hosted a focus group in which leaders from the health community were invited to share their thoughts about how Shirley Ryan AbilityLab can assist in addressing the current, significant health needs of the community. These leaders included: persons with special knowledge or expertise in public health; representatives from federal, state or local health departments; representatives of agencies with current data or other information relevant to the health needs of the community; representatives or members of medically under-served, low-income, and minority populations; and representatives of populations with chronic disease needs. Shirley Ryan AbilityLab is grateful for the discussion and input provided by the following focus group participants: * Brain Injury Association of Illinois * Illinois Department of Human Services ("DHS") - Division of Rehabilitation Services * Participant / Patient Parkinson's Disease &amp; Movement Disorder * Spinal Cord Injury Association of Illinois * Shirley Ryan AbilityLab Peer Mentor Program Group discussion focused on rehabilitation health needs of people with physical disabilities, access to information and care, research and clinical trials, education and training, and support programs. A detailed description of the participating organizations can be found in Appendix A of the CHNA. Focus group participants were asked to consider the significant rehabilitation health needs of their respective communities, and Shirley Ryan AbilityLab took their feedback into account when completing the organization's CHNA.</ExplanationTxt>
      </SupplementalInformationGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>Schedule H, Part V, Section B, Line 11 Facility , 1</FormAndLineReferenceDesc>
        <ExplanationTxt>Facility , 1 - Shirley Ryan AbilityLab. Shirley Ryan AbilityLab conducted its fourth Community Health Needs Assessment ("CHNA "Assessment") during its tax year 2021 and adopted the CHNA during its tax year 2022 (2022 CHNA). Tax year 2023 covered the period from September 1, 2023, through August 31, 2024, and is also referred to herein as FY2024. SRAlab identified the following four significant health needs in its 2022 CHNA: access to rehabilitation health, rehabilitation research, education regarding Shirley Ryan AbilityLab's resources, and post-discharge support programs. All significant health needs identified in the CHNA are being addressed. Regarding access to rehabilitation health, previous Assessments identified a need for increased access to rehabilitation health given the increasing incidence of conditions that cause cognitive and physical disabilities, specifically in the areas of stroke, spinal cord injury, brain injury, neuromusculoskeletal conditions, pediatrics and cancer. Prior to SRAlab's expansions in 2017 and 2019, SRAlab was capacity constrained by primarily semi-private rooms, gender-mix issues and infection control, but as a result of these expansions, capacity constraints affecting access have been resolved. With a current capacity at its flagship hospital of 262 private rooms with licensed beds, and despite COVID-19, SRAlab maintained and even slightly exceeded pre-COVID-19 admission rates. Currently, the average daily census is about 214 patients, but often reaches a census of 230 or more. SRAlab has also continued to increase access to care in the outpatient and DayRehab settings as well. DayRehab is a community-based program ranging from three hours of therapy per day, two days a week, to six hours of therapy per day, five days a week. SRAlab has relocated and upgraded certain DayRehab clinics, resulting in improved access to care and further supporting patients' rehabilitation health needs. Between 2018 and 2022, DayRehab cared for 23% more patients than were cared for in the previous four-year period, all as we continued to help our patients navigate their new functional abilities and medical needs in the midst of an unprecedented public health emergency. In Fiscal Year 2024, SRAlab provided approximately 20,000 telehealth and remote services with physicians, physical therapists, occupational therapists, psychologists, and speech language pathologists across all outpatient sites. SRAlab collaborates with, and will continue to collaborate with, public and private entities worldwide in conducting rehabilitation research. SRAlab is the sole academic and clinical partner of the Department of Physical Medicine &amp; Rehabilitation at Northwestern University Feinberg School of Medicine. This relationship provides an academic framework that supports SRAlab's ongoing research efforts by recruiting joint faculty and partnering on programs of mutual interest. A range of researchers are supported through this partnership, including post-doctoral researchers, pre-doctoral research graduates, physicians, residents, and other clinical fellows. In FY2024, focus areas for rehabilitation research included the use of portable sensors to monitor patient activity and response to therapy, measurement of brain network activity in chronic pain patients, and measurement of neuromuscular tissue properties in neuromuscular disease. The research conducted at SRAlab ranges from cognitive behavior and decision making to epigenetic modification of stem cells in muscle contractures. Of particular note is that measurement of brain activity for research purposes is accomplished using a research-grade magnetic resonance imaging ("MRI") scanner with a field strength (3.0 Tesla) that is twice that of the typical MRI scanner (1.5 Tesla). In addition, SRAlab's biologics lab is housed within the hospital and contains specialized facilities to perform cell culture, biochemical, biophysical, molecular and genetic studies of tissues (blood, saliva, joint fluid, muscle) obtained from SRAlab patients. Education regarding SRAlab's resources is conducted mainly, but not exclusively, through its Henry B. Betts LIFE Center ("LIFE Center"), a multimedia education center and virtual web portal, that provides access to patient education and consumer health information that is peer-reviewed and best-practice. The LIFE Center's mission is to provide opportunities for Learning, Innovation, Family, and Empowerment for the populations SRAlab serves, their families, and the community. Providing resource assistance and referral information to patients, families, staff, and the community remains the cornerstone of LIFE Center service. The LIFE Center receives and responds to thousands of resource requests from across the globe, illustrating not only the community's awareness of the LIFE Center, but also the value it provides. Resource requests are submitted to the LIFE Center in-person as well as by phone, e-mail, and mail. The LIFE Center's web traffic in FY2024 averaged 14,712 page views per month, with 176,554 page views total. This represented a 12.98% increase from the previous year. Individuals in 188 countries accessed the LIFE Center's website; the highest international web activity occurred in the United Kingdom, Australia, Canada, Philippines, India, and Germany. The fourth area of focus in the 2022 CHNA is post-discharge support programs, where the Assessment identified the continuing need for support programming. In particular, (i) support for helping patients and families manage expectations upon returning home; and (ii) developing clinical community links and formalizing communication with existing community support groups. SRAlab has, and will continue to have, numerous programs to assist patients with transitioning back to their homes and communities. SRAlab also has programs intended to help patients' families and other members of the community, regardless of whether they have been SRAlab patients. These programs include, but are not limited to, intensive Aphasia therapy, vocational rehabilitation, graduate equivalency degree classes, adaptive sports and functional fitness along with therapeutic recreation provided by experts in exercise physiology, peer mentors and support groups for caregivers. In addition to these programs, SRAlab will maintain a position in its Care Management department that is partially dedicated to working with post-discharge patients. This position provides assistance to discharged patients in areas such as nursing home placement, Durable Medical Equipment ("DME") follow up, management of transportation issues, medication management, home aide referrals, outpatient appointments, DayRehab, and transitions to home health. SRAlab intends to continue these support services at little to no cost for patients and participants.</ExplanationTxt>
      </SupplementalInformationGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>Schedule H, Part V, Section B, Line 16 Facility , 1</FormAndLineReferenceDesc>
        <ExplanationTxt>Facility , 1 - Shirley Ryan AbilityLab. The admission consent forms at all facilities explain that financial assistance is available. These forms include a contact and phone number for obtaining financial assistance and alternative payment options. Additionally, they state that financial assistance information can be found online at: www.sralab.org/charity-care-financial-assistance.</ExplanationTxt>
      </SupplementalInformationGrp>
      <FacilityNum>9</FacilityNum>
      <OthHlthCareFcltsNotHospitalGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SRAlab Burr Ridge OP &amp; DayRehab Ctr</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>7600 County Line Road</AddressLine1Txt>
            <CityNm>Burr Ridge</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60527</ZIPCd>
          </USAddress>
          <FacilityTxt>Day Rehabilitation &amp; Outpatient Rehabilitation</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>Streeterville DayRehab Center</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>345 E Superior Floors 12 13</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60611</ZIPCd>
          </USAddress>
          <FacilityTxt>Day Rehabilitation</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SRAlab Homewood - DayRehab Center</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>19260 S Halsted</AddressLine1Txt>
            <CityNm>Homewood</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60430</ZIPCd>
          </USAddress>
          <FacilityTxt>Day Rehabilitation &amp; Physician Practice</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SRALAB Arlington Heights DayRehab Center</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>3215 N Wilke Rd</AddressLine1Txt>
            <CityNm>Arlington Heights</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60004</ZIPCd>
          </USAddress>
          <FacilityTxt>Day Rehabilitation</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>Glenview Pediatric &amp; DayRehab Center</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>2591 Compass Road Suite 100</AddressLine1Txt>
            <CityNm>Glenview</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60026</ZIPCd>
          </USAddress>
          <FacilityTxt>Outpatient Rehabilitation, Day Rehabilitation &amp; Physician Practice</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SRAlab Northbrook OP Ctr (annex)</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>900 N Skokie Blvd</AddressLine1Txt>
            <CityNm>Northbrook</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60062</ZIPCd>
          </USAddress>
          <FacilityTxt>Outpatient Rehabilitation &amp; Physician Practice</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>AMITA HEALTH ALEXIAN BROS ELK GROVE</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>935 BEISNER ROAD</AddressLine1Txt>
            <CityNm>ELK GROVE VILLAGE</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60007</ZIPCd>
          </USAddress>
          <FacilityTxt>PHYSICIAN PRACTICE</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>Adaptive Sports &amp; Fitness Center</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>541 N Fairbanks Court Mezzanine</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60611</ZIPCd>
          </USAddress>
          <FacilityTxt>Outpatient</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>Vocational Rehabilitation Center</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>345 E Superior Street 12th floor</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60611</ZIPCd>
          </USAddress>
          <FacilityTxt>Specialized Services</FacilityTxt>
        </OthHlthCareFcltsGrp>
      </OthHlthCareFcltsNotHospitalGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part I, Line 7g Subsidized Health Services</FormAndLineReferenceDesc>
        <ExplanationTxt>NO COSTS ATTRIBUTABLE TO A PHYSICIAN CLINIC ARE INCLUDED ON LINE 7G.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part I, Line 7 Costing Methodology used to calculate financial assistance</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FINANCIAL ASSISTANCE AND MEANS -TESTED GOVERNMENT PROGRAMS, LINE 7A THROUGH 7C, EXPENSE IS CALCULATED BY MULTIPLYING CHARGES IN EACH CATEGORY BY THE MEDICARE COST REPORT COST TO CHARGE RATIO FOR FY 2024. THE OTHER BENEFITS, LINE 7E THROUGH 7H, EXPENSE IS CALCULATED USING BOTH DIRECT AND INDIRECT COST FOR EACH CATEGORY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part III, Line 2 Bad debt expense - methodology used to estimate amount</FormAndLineReferenceDesc>
        <ExplanationTxt>FOR FINANCIAL STATEMENT PURPOSES, SRAL HAS ADOPTED ACCOUNTING STANDARDS UPDATE NO. 2014-09 (TOPIC 606). IMPLICIT PRICE CONCESSIONS INCLUDES BAD DEBTS. THEREFORE, BAD DEBTS ARE INCLUDED IN NET PATIENT REVENUE IN ACCORDANCE WITH HEALTHCARE FINANCIAL MANAGEMENT ASSOCIATION STATEMENT NO. 15 AND BAD DEBT EXPENSE IS NOT SEPARATELY REPORTED AS AN EXPENSE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part III, Line 3 Bad Debt Expense Methodology</FormAndLineReferenceDesc>
        <ExplanationTxt>On Schedule H, Part III, Line 3 no amount was included for SRAlab for bad debt expense attributable to patients eligible under the SRAlab financial assistance policy. SRAlab's Presumptive Eligibility Policy sets forth the presumptive eligibility criteria by which a patient's financial need is determined and used by SRAlab to deem a patient eligible for hospital financial assistance without further scrutiny by SRAlab. Charity care may be provided to patients who are either uninsured or underinsured who do not have the financial resources to pay their SRAlab bill and who meet income and other guidelines specified by SRAlab. As soon as the need for financial assistance is identified, SRAlab provides the patient or Guarantor with a Program application. Patient Financial Services will review all patient accounts with self-pay balances and determine presumptive eligibility after review of the patient's Charity Application and prior to sending the patient a bill requesting payment. Patient Financial Services may use third-party reporting to determine presumptive eligibility of a patient if the patient has not timely returned a completed Charity Application. If a patient is presumed eligible, their balances will not be written off to bad debt.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part III, Line 4 Bad debt expense - financial statement footnote</FormAndLineReferenceDesc>
        <ExplanationTxt>The organization is part of the Rehabilitation Institute, Inc. and Affiliates' consolidated audit in which the footnote that discusses the bad debt expense is located on page 11.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part III, Line 8 Community benefit &amp; methodology for determining medicare costs</FormAndLineReferenceDesc>
        <ExplanationTxt>The hospital continually strives to provide excellent patient care in the most cost-effective fashion. Nonetheless, the Medicare program, in many cases, does not provide payment that covers the full cost of the care provided. The IRS does not classify this shortfall in Medicare payments as Community Benefit. However, we believe it is an important contribution made by the hospital to the health and well-being of the community. If the Medicare program did not exist, many Medicare patients would be eligible for financial assistance or other means-tested government programs. Further, by absorbing this shortfall and providing care below cost to these individuals, the hospital is relieving the burden of government. Accordingly, this shortfall restricts the hospital's ability to make funds available to provide for financial assistance and other Community Benefit.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part III, Line 9b Collection practices for patients eligible for financial assistance</FormAndLineReferenceDesc>
        <ExplanationTxt>SRALAB'S COLLECTION POLICY REQUIRES THAT, BEFORE ANY EXTRAORDINARY COLLECTION ACTIVITY IS TAKEN, AT LEAST 120 DAYS HAVE PASSED SINCE THE PATIENT'S FIRST POST-DISCHARGE BILLING STATEMENT AND THAT THE PATIENT HAS BEEN GIVEN ADEQUATE NOTICE REGARDING AND OPPORTUNITY TO APPLY FOR FINANCIAL ASSISTANCE. MOREOVER, THE POLICY REQUIRES THAT THE EXECUTIVE DIRECTOR OF REVENUE CYCLE/DESIGNEE VERIFY THAT THESE AND ALL OTHER STATUTORY PRECONDITIONS TO COLLECTION ACTIVITY HAVE BEEN MET BEFORE ANY COLLECTION ACTIVITY IS INITIATED. THE POLICY FURTHER REQUIRES THAT IF SRALAB RECEIVES A FINANCIAL ASSISTANCE APPLICATION WHILE COLLECTION ACTIVITY IS ONGOING, IT WILL SUSPEND SUCH ACTIVITY (AND REQUIRE ANY RETAINED COLLECTION AGENCIES ACTING ON ITS BEHALF TO SUSPEND SUCH ACTIVITY) SO THAT A DETERMINATION OF FINANCIAL ASSISTANCE ELIGIBILITY CAN BE MADE; IF IT IS DETERMINED THAT THE PATIENT IS ELIGIBLE FOR FINANCIAL ASSISTANCE, COLLECTION ACTIVITY WILL BE CEASED AND ANY APPLICABLE REFUNDS/REVERSALS WILL BE MADE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part V, Section B, Line 16a FAP website</FormAndLineReferenceDesc>
        <ExplanationTxt>- Shirley Ryan AbilityLab: Line 16a URL: https://www.sralab.org/charity-care-financial-assistance;</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part V, Section B, Line 16b FAP Application website</FormAndLineReferenceDesc>
        <ExplanationTxt>- Shirley Ryan AbilityLab: Line 16b URL: https://www.sralab.org/charity-care-financial-assistance;</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part V, Section B, Line 16c FAP plain language summary website</FormAndLineReferenceDesc>
        <ExplanationTxt>- Shirley Ryan AbilityLab: Line 16c URL: https://www.sralab.org/charity-care-financial-assistance;</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part VI, Line 2 Needs assessment</FormAndLineReferenceDesc>
        <ExplanationTxt>The needs of SRAlab's community are assessed on an ongoing basis as part of its routine operations and in accordance with IRS regulations relating to the Community Health Needs Assessment (CHNA). A formal assessment is performed periodically related to the CHNA. SRAlab's Henry B. Betts LIFE Center is a virtual and multimedia education center providing patient education and consumer health information for patients, families, staff and the community. Everything in the collection relates in some way to people living with a wide range of cognitive and physical impairments, chronic conditions or diseases affecting function. The website enables individuals across the globe to have access to current, peer-reviewed patient education and consumer health resources with real-time updates, printing on demand and a dashboard to save favorite resources for easy access. Resources such as the LIFE Center help individuals and their families navigate the intricacies of health care and minimize the complexity of relevant health information. Having access to information empowers people to partner with their health care team in order to make the best choices for themselves, their families and engage in life-long learning. The Center's resources are organized according to eight topic areas: Medical Information and Care, Caregiving and Equipment, Housing and Transportation, Education and Employment, Support and Wellness, Recreation and Leisure, Finance and Law and Inspiration and Hope. The LIFE Center's web traffic in FY2024 averaged 14,712 page views per month, with 176,554 page views total. This represented a 12.98% increase from the previous year. Individuals in 188 countries accessed the LIFE Center's website; the highest international web activity occurred in the United Kingdom, Australia, Canada, Philippines, India, and Germany. These activities include programs, classes, special events, resource requests, teaching activities and tours for patients, families, staff and the community.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part VI, Line 3 Patient education of eligibility for assistance</FormAndLineReferenceDesc>
        <ExplanationTxt>SRAlab ensures that each registration/admission location contains signage (in English and other predominant languages of the SRAlab patient population) notifying patients that financial assistance is available to qualified individuals. This notice is also posted on SRAlab's website (www.sralab.org), along with SRAlab's Financial Assistance Program process and application. Information regarding the Financial Assistance Program and the application is available in each SRAlab registration/admission location. Furthermore, a summary of this information is provided as part of the intake process. The information regarding financial assistance also appears on every self pay statement sent to our patients. In addition, when SRAlab care managers are involved in the patient's care, the care manager informs and assists the patients in enrolling in appropriate entitlement programs.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part VI, Line 4 Community information</FormAndLineReferenceDesc>
        <ExplanationTxt>As a specialty hospital, SRAlab defines the patients it serves broadly as the disabled community throughout the state of Illinois, the United States and around the world. Due to SRAlab's unique services and its reputation as the leader in rehabilitation medicine, many patients will travel long distances for care. Approximately 80% of SRAlab inpatients come from Chicago and its 8 surrounding counties. This represents a primary reach of approximately 60 miles. Approximately 20% of the population for whom poverty status is determined in Chicago live below the poverty line. (Source: https://datausa.io/profile/geo/chicago-il). Percentage of hospital's patients who are uninsured or Medicaid is 20% within Cook County; where SRAlab is located, there are 24 Medically under-served areas for Primary Care. (Source: https:// data.hrsa.gov/tools/shortage-area/mua-find). Within the city of Chicago, there are approximately 25 hospitals serving approximately 3 million people. In addition, to Chicago area patients, SRAlab also cared for patients from 40 states and handled referrals from 50 countries. SRAlab continues to increase its outreach and has impacted the lives of individuals in North, Central and South America; Europe; Africa; Asia (predominately the Middle East); and Australia. The largest users of rehabilitation medicine are those over the age of 65. However, SRAlab continues to serve patients of all ages, including pediatrics. In addition, SRAlab conducts strategic planning around patients of varying ages.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part VI, Line 5 Promotion of community health</FormAndLineReferenceDesc>
        <ExplanationTxt>SRAlab's governing body is chiefly comprised of persons who reside in the organization's primary service area who are neither employees nor independent contractors of the organization, nor family members thereof. SRAlab, extends medical staff privileges to qualified physicians. SRAlab provides a number of services that generally do not generate revenue, solely for the purposes of improving the health and quality of life for our community. These services include: research to improve patient outcomes; educational resources on living with a disability available to anyone through the Internet; vocational training and placement services; support groups to assist in psychological adjustment; fitness and sports training program to promote physical activity and case management for high risk patients discharged to the community. Any surplus funds are applied to patient care, education and research as highlighted in greater detail within part III of the Form 990. Surplus funds are allocated during the annual budget process, which includes Board approval.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule H, Part VI, Line 7 State filing of community benefit report</FormAndLineReferenceDesc>
        <ExplanationTxt>IL</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleH>
    <IRS990ScheduleI documentId="IRS990ScheduleI" softwareId="23017437" softwareVersionNum="2023v6.0">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Center For Veterans Research And Education</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1 Veterans Drive Suite 3M</AddressLine1Txt>
          <CityNm>Minneapolis</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55417</ZIPCd>
        </USAddress>
        <RecipientEIN>411652941</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>67647</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Cirtec Medical LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>11 Cooper Court</AddressLine1Txt>
          <CityNm>Los Gatos</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>95032</ZIPCd>
        </USAddress>
        <RecipientEIN>208007459</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>5719</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Florida International University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>112 SW 8th Street</AddressLine1Txt>
          <AddressLine2Txt>Marc-430</AddressLine2Txt>
          <CityNm>Miami</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>33199</ZIPCd>
        </USAddress>
        <RecipientEIN>650177616</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>17377</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Access Living Of Metropolitan Chicago</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>115 West Chicago Avenue</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60654</ZIPCd>
        </USAddress>
        <RecipientEIN>363310774</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>86810</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of North Texas</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1155 Union Circle 311277</AddressLine1Txt>
          <CityNm>Denton</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>762035017</ZIPCd>
        </USAddress>
        <RecipientEIN>756002149</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>37717</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Kessler Foundation</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>12 Eagle Rock Avenue</AddressLine1Txt>
          <CityNm>East Hanover</CityNm>
          <StateAbbreviationCd>NJ</StateAbbreviationCd>
          <ZIPCd>079363147</ZIPCd>
        </USAddress>
        <RecipientEIN>311562134</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>69408</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>President And Fellows Of Harvard College Dba Harvard University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>133 Massachusetts Avenue 2nd floor</AddressLine1Txt>
          <CityNm>Cambridge</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02138</ZIPCd>
        </USAddress>
        <RecipientEIN>042103580</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>49686</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Medical Engineering &amp; Development Institute Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>133 Win Hentschel Blvd</AddressLine1Txt>
          <CityNm>West Lafayette</CityNm>
          <StateAbbreviationCd>IN</StateAbbreviationCd>
          <ZIPCd>47906</ZIPCd>
        </USAddress>
        <RecipientEIN>473049436</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>87270</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Inchworms Pediatric Therapy LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>135 W Diversey Parkway</AddressLine1Txt>
          <AddressLine2Txt>Unit 1</AddressLine2Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60614</ZIPCd>
        </USAddress>
        <RecipientEIN>861882100</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>9453</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Illinois</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>135 W Green Street</AddressLine1Txt>
          <CityNm>Urbana</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>61801</ZIPCd>
        </USAddress>
        <RecipientEIN>376000511</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>905684</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Shepherd Center</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>22 Peachtree Road NW</AddressLine1Txt>
          <CityNm>Atlanta</CityNm>
          <StateAbbreviationCd>GA</StateAbbreviationCd>
          <ZIPCd>30309</ZIPCd>
        </USAddress>
        <RecipientEIN>510141601</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>166808</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>HCBS Strategies Incorporated</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>222 Ridgewood Rd</AddressLine1Txt>
          <CityNm>Baltimore</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>21210</ZIPCd>
        </USAddress>
        <RecipientEIN>200958373</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>55820</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Mary Free Bed Hospital &amp; Rehabilitation Center</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>235 Wealthy Street SE</AddressLine1Txt>
          <CityNm>Grand Rapids</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>495035299</ZIPCd>
        </USAddress>
        <RecipientEIN>381359265</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>61664</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Advancing States Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>241 18th Street Suite 43</AddressLine1Txt>
          <CityNm>Arlington</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22202</ZIPCd>
        </USAddress>
        <RecipientEIN>396095459</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>43000</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Marianjoy Rehabilitation Hospital &amp; Clinics Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>26 W 171 Roosevelt Road</AddressLine1Txt>
          <CityNm>Wheaton</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60187</ZIPCd>
        </USAddress>
        <RecipientEIN>362680776</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>6852</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>North Carolina State University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>271 Sullivan Drive Campus Box 7514</AddressLine1Txt>
          <CityNm>Raleigh</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>276957514</ZIPCd>
        </USAddress>
        <RecipientEIN>566000756</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>90696</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Colorado-Boulder</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>31 Main Street</AddressLine1Txt>
          <CityNm>Boulder</CityNm>
          <StateAbbreviationCd>CO</StateAbbreviationCd>
          <ZIPCd>803090572</ZIPCd>
        </USAddress>
        <RecipientEIN>846000555</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>174803</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Research Triangle Institute</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>34 East Cornwallis Road POBox 12</AddressLine1Txt>
          <CityNm>Research Triangle Park</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>277092194</ZIPCd>
        </USAddress>
        <RecipientEIN>560686338</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>115970</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Southern California</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>35 South Figueroa Street Suite 12</AddressLine1Txt>
          <CityNm>Los Angeles</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>900898001</ZIPCd>
        </USAddress>
        <RecipientEIN>951642394</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>104685</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Northeastern University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>36 Huntington Avenue</AddressLine1Txt>
          <CityNm>Boston</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>041679980</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>28301</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Washington</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3917 University Way NE</AddressLine1Txt>
          <CityNm>Seattle</CityNm>
          <StateAbbreviationCd>WA</StateAbbreviationCd>
          <ZIPCd>981051122</ZIPCd>
        </USAddress>
        <RecipientEIN>916001537</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>121751</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Cares - Chicago Association For Research &amp; Education In Science</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5s 5th Avenue Bldg One</AddressLine1Txt>
          <CityNm>Hines</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60141</ZIPCd>
        </USAddress>
        <RecipientEIN>363334177</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>21782</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Alabama - Birmingham</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>71 2th Street South 77 Admin Bldg</AddressLine1Txt>
          <CityNm>Birmingham</CityNm>
          <StateAbbreviationCd>AL</StateAbbreviationCd>
          <ZIPCd>35294</ZIPCd>
        </USAddress>
        <RecipientEIN>636005396</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>67303</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Northwestern University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>71 N Lakeshore Drive</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <RecipientEIN>362167817</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>1898113</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Virginia Commonwealth University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>8 E Leigh St Suite 32 Box 98568</AddressLine1Txt>
          <CityNm>Richmond</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>232980568</ZIPCd>
        </USAddress>
        <RecipientEIN>546001758</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>12820</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>National University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>9388 Lightwave Avenue</AddressLine1Txt>
          <CityNm>San Diego</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>92123</ZIPCd>
        </USAddress>
        <RecipientEIN>237172306</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>649810</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>New York University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO Box 5166</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10087</ZIPCd>
        </USAddress>
        <RecipientEIN>135562308</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>5309</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Beth Israel Deaconess Medical Center Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>330 Brookline Avenue</AddressLine1Txt>
          <CityNm>Boston</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02215</ZIPCd>
        </USAddress>
        <RecipientEIN>042103881</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>16502</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Cincinnati</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>Sponsored Research Services</AddressLine1Txt>
          <AddressLine2Txt>PO Box 2122</AddressLine2Txt>
          <CityNm>Cincinnati</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>45221</ZIPCd>
        </USAddress>
        <RecipientEIN>316000989</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>22585</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Florida</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>Suite 125 East Campus Building</AddressLine1Txt>
          <CityNm>Gainesville</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>32611</ZIPCd>
        </USAddress>
        <RecipientEIN>596002052</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>75126</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Baylor Research Institute Dba Baylor Scott &amp; White Research Institute</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3434 Live Oak Street Suite 501</AddressLine1Txt>
          <CityNm>Dallas</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>75204</ZIPCd>
        </USAddress>
        <RecipientEIN>751921898</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>21248</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Brett Mensh Optimize Science</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>37 Joseph Court</AddressLine1Txt>
          <CityNm>San Rafael</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94903</ZIPCd>
        </USAddress>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>23470</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Carnegie Mellon University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO Box 371032</AddressLine1Txt>
          <CityNm>Pittsburg</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>152507032</ZIPCd>
        </USAddress>
        <RecipientEIN>250969449</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>42075</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Chicago Park District</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>541 N Fairbanks Court 4Th Fl</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <RecipientEIN>366005822</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>6000</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Datos Health Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>333 West 52nd Street Suite 1208</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10019</ZIPCd>
        </USAddress>
        <RecipientEIN>815286317</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>50000</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>DJS Scuba Locker Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>9301 West Ogden</AddressLine1Txt>
          <CityNm>Brookfield</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60513</ZIPCd>
        </USAddress>
        <RecipientEIN>363999047</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>5000</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Handicare USA LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO Box 7411090</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>606741090</ZIPCd>
        </USAddress>
        <RecipientEIN>203625394</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>9177</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Health Tech Pal Corp</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1930 Marlton Pike East Suite Q37</AddressLine1Txt>
          <CityNm>Cherry Hill</CityNm>
          <StateAbbreviationCd>NJ</StateAbbreviationCd>
          <ZIPCd>08003</ZIPCd>
        </USAddress>
        <RecipientEIN>464086450</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>13578</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Kozlowski Health Services Consulting LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1024 Sherman Street Se</AddressLine1Txt>
          <CityNm>Grand Rapids</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>49506</ZIPCd>
        </USAddress>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>6500</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>KTD Plus LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1008 Ashland Avenue</AddressLine1Txt>
          <CityNm>Evanston</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60202</ZIPCd>
        </USAddress>
        <RecipientEIN>872054485</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>31000</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>North Side Archery Club</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5820 North Sheridan Road 211</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60660</ZIPCd>
        </USAddress>
        <RecipientEIN>811137498</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>5300</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Rancho Research Institute</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO Box 3500</AddressLine1Txt>
          <CityNm>Downey</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90242</ZIPCd>
        </USAddress>
        <RecipientEIN>951911180</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>42976</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Regents Of The University Of Minnesota</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2221 University Avenue SE</AddressLine1Txt>
          <AddressLine2Txt>Suite 111</AddressLine2Txt>
          <CityNm>Minneapolis</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55414</ZIPCd>
        </USAddress>
        <RecipientEIN>416007513</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>21889</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>San Diego State University Foundation</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5250 Campanile Drive MC 1947</AddressLine1Txt>
          <CityNm>San Diego</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>921821947</ZIPCd>
        </USAddress>
        <RecipientEIN>956042721</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>9150</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Support Development Associates LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>604 Leawood Drive</AddressLine1Txt>
          <CityNm>Greensboro</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27410</ZIPCd>
        </USAddress>
        <RecipientEIN>753244685</RecipientEIN>
        <IRCSectionDesc>N/A</IRCSectionDesc>
        <CashGrantAmt>16114</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>The University Of Chicago</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>6054 S Drexel Avenue</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60637</ZIPCd>
        </USAddress>
        <RecipientEIN>362177139</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>55309</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of California Irvine</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>Contracts Grants Accounting</AddressLine1Txt>
          <AddressLine2Txt>228 Aldrich Hall</AddressLine2Txt>
          <CityNm>Irvine</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>926971050</ZIPCd>
        </USAddress>
        <RecipientEIN>952226406</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>275138</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Houston</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>TreasurerS Office PO Box 988</AddressLine1Txt>
          <CityNm>Houston</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>77001</ZIPCd>
        </USAddress>
        <RecipientEIN>746001399</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>38750</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University Of Utah</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>201 S Presidents Circle Rm 406</AddressLine1Txt>
          <CityNm>Salt Lake City</CityNm>
          <StateAbbreviationCd>UT</StateAbbreviationCd>
          <ZIPCd>84112</ZIPCd>
        </USAddress>
        <RecipientEIN>876000525</RecipientEIN>
        <IRCSectionDesc>Government Entity</IRCSectionDesc>
        <CashGrantAmt>11838</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>William Marsh Rice University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO Box 1892 MS 74</AddressLine1Txt>
          <CityNm>Houston</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>772511892</ZIPCd>
        </USAddress>
        <RecipientEIN>741109620</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>31331</CashGrantAmt>
        <PurposeOfGrantTxt>Payments for research study related activities</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NF Forward</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1074 Woodward Avenue</AddressLine1Txt>
          <CityNm>Detroit</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48226</ZIPCd>
        </USAddress>
        <RecipientEIN>821672519</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>8000</CashGrantAmt>
        <PurposeOfGrantTxt>Operational Support</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Ascension Illinois Foundation</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>100 Remington Blvd</AddressLine1Txt>
          <CityNm>Bolingbrook</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60440</ZIPCd>
        </USAddress>
        <RecipientEIN>363260495</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>5000</CashGrantAmt>
        <PurposeOfGrantTxt>Operational Support</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>40</Total501c3OrgCnt>
      <TotalOtherOrgCnt>12</TotalOtherOrgCnt>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Stipends</GrantTypeTxt>
        <RecipientCnt>3</RecipientCnt>
        <CashGrantAmt>4212</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Research - Professional fees &amp; Purchased Services</GrantTypeTxt>
        <RecipientCnt>96</RecipientCnt>
        <CashGrantAmt>181846</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>Subject Reimbursements</GrantTypeTxt>
        <RecipientCnt>6661</RecipientCnt>
        <CashGrantAmt>348717</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds.</FormAndLineReferenceDesc>
        <ExplanationTxt>OVERSIGHT IS PROVIDED BY EXECUTIVE LEADERSHIP, SUPPORTED BY THE RESEARCH ADMINISTRATION DEPARTMENT WHERE ACTIVE INTERACTION WITH PRINCIPAL INVESTIGATORS IS MAINTAINED. MONITORING IS DONE THROUGH CONTINUED RELATIONSHIPS WITH GRANTEE ORGANIZATIONS or INDIVIDUALS, WHETHER BY MEMBERSHIP OR COMMUNITY LIAISON. FOR RESEARCH GRANTS, EACH GRANT IS ASSIGNED A PRINCIPAL INVESTIGATOR (PI) AS WELL AS A RESEARCH ASSISTANT (RA). GRANT EXPENDITURES CHARGED TO EACH GRANT ARE APPROVED/REVIEWED BY THE RESPECTIVE PI AND/OR RA TO ENSURE ALLOWABILITY. IN ADDITION, COMPLIANCE (A-133) AS WELL AS FINANCIAL AUDITS ARE PERFORMED BY AN INDEPENDENT AUDIT FIRM EACH YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="IRS990ScheduleJ" softwareId="23017437" softwareVersionNum="2023v6.0">
      <FirstClassOrCharterTravelInd>X</FirstClassOrCharterTravelInd>
      <TravelForCompanionsInd>X</TravelForCompanionsInd>
      <WrittenPolicyRefTAndEExpnssInd>true</WrittenPolicyRefTAndEExpnssInd>
      <SubstantiationRequiredInd>true</SubstantiationRequiredInd>
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <IndependentConsultantInd>X</IndependentConsultantInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>true</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Peggy M Kirk</PersonNm>
        <TitleTxt>President, CEO (ending 1/1/2024)</TitleTxt>
        <BaseCompensationFilingOrgAmt>992050</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>690000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>1128994</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>1430175</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>27907</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>4269126</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>1077325</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Pablo Celnik MD</PersonNm>
        <TitleTxt>Chief Executive Officer (Beginning 9/23/23)</TitleTxt>
        <BaseCompensationFilingOrgAmt>262894</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>463433</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>1548</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>6955</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>734830</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Nancy E Paridy</PersonNm>
        <TitleTxt>President, Chief Administrative Officer</TitleTxt>
        <BaseCompensationFilingOrgAmt>820684</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>570000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>724621</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>632789</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>26163</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>2774257</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>686677</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Jonathan M Tingstad</PersonNm>
        <TitleTxt>SVP, Chief Financial Officer</TitleTxt>
        <BaseCompensationFilingOrgAmt>669442</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>340000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>92631</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>59828</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>46106</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>1208007</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>60069</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Laura L Ferrio</PersonNm>
        <TitleTxt>SVP, Chief Operating Officer</TitleTxt>
        <BaseCompensationFilingOrgAmt>529221</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>245000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>30938</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>48685</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>29857</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>883701</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Richard Lieber PhD</PersonNm>
        <TitleTxt>SVP of Research, Chief Scientific Officer</TitleTxt>
        <BaseCompensationFilingOrgAmt>726433</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>365000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>114227</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>54531</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>26287</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>1286478</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>62009</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Elizabeth Owens</PersonNm>
        <TitleTxt>SVP, Chief Marketing and Innovation Officer</TitleTxt>
        <BaseCompensationFilingOrgAmt>624762</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>315000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>257362</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>62844</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>25240</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>1285208</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>205693</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>James Sliwa DO</PersonNm>
        <TitleTxt>Chief Medical Officer</TitleTxt>
        <BaseCompensationFilingOrgAmt>577284</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>287000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>48204</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>39416</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>27771</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>979675</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>Kelly Watkins</PersonNm>
        <TitleTxt>VP, Market Development</TitleTxt>
        <BaseCompensationFilingOrgAmt>348391</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>130000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>304912</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>174326</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>26151</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>983780</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>270395</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>David J Weiss</PersonNm>
        <TitleTxt>Medical Director</TitleTxt>
        <BaseCompensationFilingOrgAmt>610163</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>68000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>31645</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>2906</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>13596</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>726310</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule J, Part I, Line 1a First-class or charter travel</FormAndLineReferenceDesc>
        <ExplanationTxt>Certain employees traveled first class for SRAlab related business in FY 2024. Individuals who received this benefit during the year include: Dr. Pablo Celnik, Chief Executive Officer Nancy Paridy, President, Chief Adminisrative Officer Laura Ferrio, SVP, Chief Operating Officer Elizabeth Owens, SVP, Chief Marketing Officer Dr. James Sliwa, Chief Medical Officer This travel benefit was not treated as taxable compensation.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule J, Part I, Line 1a Travel for companions</FormAndLineReferenceDesc>
        <ExplanationTxt>SRAlab covered companion travel for certain employees during FY 2024. Individuals who received this benefit during the year include: Dr. Pablo Celnik, Chief Executive Officer Laura Ferrio, SVP, Chief Operating Officer This travel benefit was not treated as taxable compensation.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan</FormAndLineReferenceDesc>
        <ExplanationTxt>Eligible executives participate in various non-qualified deferred compensation plans organized under code section 457(F). The exact purpose of each plan varies, but they include: compensation limitation make-up plans, voluntary deferral plans, deferral of a portion of incentive bonus type plans, etc. Any amount ultimately paid under the program to the executive is reported as compensation on Form 990, Schedule J, Part II, Column B in the year paid. The following listed person(s) participated in the 457(F) plan and received plan payments as follows: Nancy E. Paridy - $686,677 Peggy M. Kirk - $1,077,325 Jonathan Tingstad - $60,069 Elizabeth Owens - $205,693 Richard Lieber, Ph.D. $62,009 Kelly Watkins - $270,395 THE FOLLOWING INTERESTED PERSONS CONSTRUCTIVELY RECEIVED DEFERRALS TO THE 457(F) PLAN IN CY 2023 THESE DEFERRALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (C). NANCY E. PARIDY - $519,512 PEGGY M. KIRK - $1,356,004 JONATHAN TINGSTAD - $17,780 ELIZABETH OWENS - $13,684 RICHARD LIEBER, PH.D.-$22,504 KELLY WATKINS - $167,908</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule J, Part I, Line 7 NON-FIXED PAYMENTS</FormAndLineReferenceDesc>
        <ExplanationTxt>Executive leadership participate in a variable incentive compensation plan. Amounts are a percent of base salary. Certain financial and quality triggers need to be met, and then the percent awards are determined by institutional financial performance, quality indicators, and individual performance metrics. BY DEFINITION, THESE ARE NOT CONSIDERED TO BE NON-FIXED PAYMENTS, AS DEFINED BY THE INSTRUCTIONS TO SCHEDULE J OF THE FORM 990, HOWEVER, THE ORGANIZATION IS DISCLOSING THIS INFORMATION IN AN EFFORT TO BE TRANSPARENT IN ITS COMPENSATION PRACTICES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleK documentId="IRS990ScheduleK1" softwareId="23017437" softwareVersionNum="2023v6.0">
      <TaxExemptBondsIssuesGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <IssuerName>
          <BusinessNameLine1Txt>Illinois Finance Authority</BusinessNameLine1Txt>
        </IssuerName>
        <BondIssuerEIN>861091967</BondIssuerEIN>
        <CUSIPNum>000000000</CUSIPNum>
        <BondIssuedDt>2016-12-01</BondIssuedDt>
        <IssuePriceAmt>274055000</IssuePriceAmt>
        <PurposeDesc>Refund of Series 2013B-E bonds issued 7/11/2013</PurposeDesc>
        <DefeasedInd>false</DefeasedInd>
        <OnBehalfOfIssuerInd>false</OnBehalfOfIssuerInd>
        <PoolFinancingInd>false</PoolFinancingInd>
      </TaxExemptBondsIssuesGrp>
      <TaxExemptBondsIssuesGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <IssuerName>
          <BusinessNameLine1Txt>Illinois Finance Authority</BusinessNameLine1Txt>
        </IssuerName>
        <BondIssuerEIN>861091967</BondIssuerEIN>
        <CUSIPNum>45204FPG4</CUSIPNum>
        <BondIssuedDt>2023-04-03</BondIssuedDt>
        <IssuePriceAmt>84061709</IssuePriceAmt>
        <PurposeDesc>Defeasance of 2013A bond series issued 7/11/2013</PurposeDesc>
        <DefeasedInd>true</DefeasedInd>
        <OnBehalfOfIssuerInd>false</OnBehalfOfIssuerInd>
        <PoolFinancingInd>false</PoolFinancingInd>
      </TaxExemptBondsIssuesGrp>
      <TaxExemptBondsProceedsGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <RetiredAmt>83840000</RetiredAmt>
        <BondDefeasedAmt>0</BondDefeasedAmt>
        <TotalProceedsAmt>274055000</TotalProceedsAmt>
        <InReserveFundAmt>0</InReserveFundAmt>
        <CapitalizedInterestAmt>0</CapitalizedInterestAmt>
        <RefundingEscrowAmt>0</RefundingEscrowAmt>
        <IssuanceCostsFromProceedsAmt>1055000</IssuanceCostsFromProceedsAmt>
        <CreditEnhancementAmt>0</CreditEnhancementAmt>
        <WorkingCapitalExpendituresAmt>0</WorkingCapitalExpendituresAmt>
        <CapitalExpendituresAmt>0</CapitalExpendituresAmt>
        <OtherSpentProceedsAmt>273000000</OtherSpentProceedsAmt>
        <UnspentAmt>0</UnspentAmt>
        <SubstantialCompletionYr>2017</SubstantialCompletionYr>
        <RefundingTaxExemptBondsInd>true</RefundingTaxExemptBondsInd>
        <RefundingTaxableBondsInd>false</RefundingTaxableBondsInd>
        <FinalAllocationMadeInd>true</FinalAllocationMadeInd>
        <AdequateBooksAndRecMaintInd>true</AdequateBooksAndRecMaintInd>
      </TaxExemptBondsProceedsGrp>
      <TaxExemptBondsProceedsGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <RetiredAmt>2995000</RetiredAmt>
        <BondDefeasedAmt>82262512</BondDefeasedAmt>
        <TotalProceedsAmt>84061709</TotalProceedsAmt>
        <InReserveFundAmt>0</InReserveFundAmt>
        <CapitalizedInterestAmt>0</CapitalizedInterestAmt>
        <RefundingEscrowAmt>0</RefundingEscrowAmt>
        <IssuanceCostsFromProceedsAmt>827180</IssuanceCostsFromProceedsAmt>
        <CreditEnhancementAmt>0</CreditEnhancementAmt>
        <WorkingCapitalExpendituresAmt>0</WorkingCapitalExpendituresAmt>
        <CapitalExpendituresAmt>0</CapitalExpendituresAmt>
        <OtherSpentProceedsAmt>83234529</OtherSpentProceedsAmt>
        <UnspentAmt>0</UnspentAmt>
        <SubstantialCompletionYr>2023</SubstantialCompletionYr>
        <RefundingTaxExemptBondsInd>true</RefundingTaxExemptBondsInd>
        <RefundingTaxableBondsInd>false</RefundingTaxableBondsInd>
        <FinalAllocationMadeInd>true</FinalAllocationMadeInd>
        <AdequateBooksAndRecMaintInd>true</AdequateBooksAndRecMaintInd>
      </TaxExemptBondsProceedsGrp>
      <TaxExemptBondsPrivateBusUseGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <OwningBondFinancedPropertyInd>false</OwningBondFinancedPropertyInd>
        <AnyLeaseArrangementsInd>false</AnyLeaseArrangementsInd>
        <MgmtContractBondFincdPropInd>true</MgmtContractBondFincdPropInd>
        <EngageBondCounselContractsInd>true</EngageBondCounselContractsInd>
        <AnyResearchAgreementsInd>true</AnyResearchAgreementsInd>
        <EngageBondCounselResearchInd>true</EngageBondCounselResearchInd>
        <PrivateBusUseByOthersPct>0.0</PrivateBusUseByOthersPct>
        <PrivateBusConcerningUBIPct>0.0</PrivateBusConcerningUBIPct>
        <TotalPrivateBusinessUsePct>0.0</TotalPrivateBusinessUsePct>
        <BondIssMeetPrvtSecPymtTestInd>false</BondIssMeetPrvtSecPymtTestInd>
        <ChangeInUseBondFinancedPropInd>false</ChangeInUseBondFinancedPropInd>
        <ProcsNonqualifiedBondRemdtdInd>true</ProcsNonqualifiedBondRemdtdInd>
      </TaxExemptBondsPrivateBusUseGrp>
      <TaxExemptBondsPrivateBusUseGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <OwningBondFinancedPropertyInd>false</OwningBondFinancedPropertyInd>
        <AnyLeaseArrangementsInd>false</AnyLeaseArrangementsInd>
        <MgmtContractBondFincdPropInd>true</MgmtContractBondFincdPropInd>
        <EngageBondCounselContractsInd>true</EngageBondCounselContractsInd>
        <AnyResearchAgreementsInd>true</AnyResearchAgreementsInd>
        <EngageBondCounselResearchInd>true</EngageBondCounselResearchInd>
        <PrivateBusUseByOthersPct>0.0</PrivateBusUseByOthersPct>
        <PrivateBusConcerningUBIPct>0.0</PrivateBusConcerningUBIPct>
        <TotalPrivateBusinessUsePct>0.0</TotalPrivateBusinessUsePct>
        <BondIssMeetPrvtSecPymtTestInd>false</BondIssMeetPrvtSecPymtTestInd>
        <ChangeInUseBondFinancedPropInd>false</ChangeInUseBondFinancedPropInd>
        <ProcsNonqualifiedBondRemdtdInd>true</ProcsNonqualifiedBondRemdtdInd>
      </TaxExemptBondsPrivateBusUseGrp>
      <TaxExemptBondsArbitrageGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <Form8038TFiledInd>false</Form8038TFiledInd>
        <RebateNotDueYetInd>false</RebateNotDueYetInd>
        <ExceptionToRebateInd>false</ExceptionToRebateInd>
        <NoRebateDueInd>true</NoRebateDueInd>
        <VariableRateIssueInd>true</VariableRateIssueInd>
        <HedgeIdentifiedInBksAndRecInd>false</HedgeIdentifiedInBksAndRecInd>
        <GrossProceedsInvestedInGICInd>false</GrossProceedsInvestedInGICInd>
        <GrossProceedsInvestedInd>false</GrossProceedsInvestedInd>
        <WrittenProcToMonitorReqsInd>true</WrittenProcToMonitorReqsInd>
      </TaxExemptBondsArbitrageGrp>
      <TaxExemptBondsArbitrageGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <Form8038TFiledInd>false</Form8038TFiledInd>
        <RebateNotDueYetInd>true</RebateNotDueYetInd>
        <ExceptionToRebateInd>false</ExceptionToRebateInd>
        <NoRebateDueInd>false</NoRebateDueInd>
        <VariableRateIssueInd>false</VariableRateIssueInd>
        <HedgeIdentifiedInBksAndRecInd>false</HedgeIdentifiedInBksAndRecInd>
        <GrossProceedsInvestedInGICInd>false</GrossProceedsInvestedInGICInd>
        <GrossProceedsInvestedInd>false</GrossProceedsInvestedInd>
        <WrittenProcToMonitorReqsInd>true</WrittenProcToMonitorReqsInd>
      </TaxExemptBondsArbitrageGrp>
      <ProceduresCorrectiveActionGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <ProceduresCorrectiveActionInd>false</ProceduresCorrectiveActionInd>
      </ProceduresCorrectiveActionGrp>
      <ProceduresCorrectiveActionGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <ProceduresCorrectiveActionInd>false</ProceduresCorrectiveActionInd>
      </ProceduresCorrectiveActionGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule K, Part III, Line 9 Part IV, Line 7, and Part V</FormAndLineReferenceDesc>
        <ExplanationTxt>The organization does not have written compliance procedures. However, we are aware of each of these requirements (section 1.141-12 self-remediation procedures, arbitrage restrictions, VCAP), and we will seek professional assistance at the appropriate time, as necessary.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule K, Part IV, Line 2c COLUMN A</FormAndLineReferenceDesc>
        <ExplanationTxt>Issuer name: Illinois Finance Authority The calculation for computing no rebate due was performed on 06/07/2021</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleK>
    <IRS990ScheduleL documentId="IRS990ScheduleL" softwareId="23017437" softwareVersionNum="2023v6.0">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>Substantial Contributor</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Substantial Contributor</RelationshipDescriptionTxt>
        <TransactionAmt>689240</TransactionAmt>
        <TransactionDesc>Consulting &amp; Risk Services</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>Substantial Contributor</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Substantial Contributor</RelationshipDescriptionTxt>
        <TransactionAmt>638330</TransactionAmt>
        <TransactionDesc>Legal Services</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>Substantial Contributor</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Substantial Contributor</RelationshipDescriptionTxt>
        <TransactionAmt>322225</TransactionAmt>
        <TransactionDesc>Pharmaceutical Goods &amp; Services</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>Substantial Contributor</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Substantial Contributor</RelationshipDescriptionTxt>
        <TransactionAmt>277399</TransactionAmt>
        <TransactionDesc>Legal Services</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>Substantial Contributor</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Substantial Contributor</RelationshipDescriptionTxt>
        <TransactionAmt>600069</TransactionAmt>
        <TransactionDesc>IT Consulting</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>Substantial Contributor</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Substantial Contributor</RelationshipDescriptionTxt>
        <TransactionAmt>129054</TransactionAmt>
        <TransactionDesc>Industrial Supplies</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>Substantial Contributor</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Substantial Contributor</RelationshipDescriptionTxt>
        <TransactionAmt>470985</TransactionAmt>
        <TransactionDesc>Construction Services</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>SRALAB Employee</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>Relative of Board Member</RelationshipDescriptionTxt>
        <TransactionAmt>77556</TransactionAmt>
        <TransactionDesc>Wages</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule L, Part V Business Transactions Involving Interested Persons:</FormAndLineReferenceDesc>
        <ExplanationTxt>All transactions between SRAlab and interested persons were done at arms-length and at fair market value.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="IRS990ScheduleM" softwareId="23017437" softwareVersionNum="2023v6.0">
      <ClothingAndHouseholdGoodsGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <NoncashContributionsRptF990Amt>3000</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>Market value</MethodOfDeterminingRevenuesTxt>
      </ClothingAndHouseholdGoodsGrp>
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>12</ContributionCnt>
        <NoncashContributionsRptF990Amt>765896</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>Market value</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <FoodInventoryGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>8</ContributionCnt>
        <NoncashContributionsRptF990Amt>6020</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>Market value</MethodOfDeterminingRevenuesTxt>
      </FoodInventoryGrp>
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>Gift Certficates</Desc>
        <ContributionCnt>15</ContributionCnt>
        <NoncashContributionsRptF990Amt>5590</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>Market value</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>Event Tickets</Desc>
        <ContributionCnt>7</ContributionCnt>
        <NoncashContributionsRptF990Amt>2566</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>Market value</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>Entertainment</Desc>
        <ContributionCnt>11</ContributionCnt>
        <NoncashContributionsRptF990Amt>12476</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>Market value</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>Hotel Accomodations</Desc>
        <ContributionCnt>8</ContributionCnt>
        <NoncashContributionsRptF990Amt>5293</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>Market value</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <Form8283ReceivedCnt>0</Form8283ReceivedCnt>
      <AnyPropertyThatMustBeHeldInd>false</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>true</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>false</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Schedule M, Part I Explanations of reporting method for number of contributions</FormAndLineReferenceDesc>
        <ExplanationTxt>Other - Gift Certficates The number in Column (b) refers to the number of contributions. Other - Event Tickets The number in Column (b) refers to the number of contributions. Other - Entertainment The number in Column (b) refers to the number of contributions. Other - Hotel Accomodations The number in Column (b) refers to the number of contributions. Food inventory - Food / Spirits The number in Column (b) refers to the number of contributions. Clothing and household goods - The number in Column (b) refers to the number of items received Securities - Publicly traded - The number in Column (b) refers to the number of contributions.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="IRS990ScheduleO" softwareId="23017437" softwareVersionNum="2023v6.0">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d Description of other program services</FormAndLineReferenceDesc>
        <ExplanationTxt>(Expenses $ 6,088,841 including grants of $)(Revenue $ 694,219) SRAlab's Henry B. Betts LIFE Center is a virtual and multimedia education center providing patient education and consumer health information for patients, families, staff and the community. Everything in the collection relates in some way to people living with a wide range of cognitive and physical impairments, chronic conditions or diseases affecting function. The website enables individuals across the globe to have access to current, peer-reviewed patient education and consumer health resources with real-time updates, printing on demand and a dashboard to save favorite resources for easy access. Resources such as the LIFE Center help individuals, and their families navigate the intricacies of health care and minimize the complexity of relevant health information. Having access to information empowers people to partner with their health care team to make the best choices for themselves, their families and engage in life-long learning. The Center's resources are organized according to eight topic areas: Medical Information and Care, Caregiving and Equipment, Housing and Transportation, Education and Employment, Support and Wellness, Recreation and Leisure, Finance and Law and Inspiration and Hope. LIFE web traffic in FY 2024 averaged 14,712 page views per month, up from 13,023 page views per month in FY 2023, with 176,554 page views annually, up from 156,274 page views annually in FY 2023 from more than 188 countries. This past year, the highest international web activity occurred in the United Kingdom, Australia, India, Canada, Philippines, and Germany. In FY 2024, total outreach and service efforts apart from web activity was 7,683 person contacts served which includes programs, classes, special events, resource requests, teaching activities, peer mentoring events and tours for patients, families, staff and the community. Sports and Fitness Program: The SRAlab Adaptive Sports and Fitness Program provides wellness opportunities to people with physical disabilities through sports and recreation as well as an accessible Fitness Center. All services offered in the adaptive sports program, which marked its 43rd year in FY 2024, are free of charge. The fitness programs, which celebrated its 28th anniversary, provides access to a 1-on-1 functional fitness activities and group fitness classes that operate between 6:15 am and 7 pm five days per week for a nominal participation fee. The sports and fitness program is funded primarily by grants and generous community donations and is operated by twelve full time equivalent staff. Additionally, volunteers logged nearly 8000 hours in FY 2024. The Shirley Ryan Adaptive Sports and Fitness Program is considered a national leader in health promotion for people with disabilities. In FY 2024 we continued to expand programming developing new initiatives to promote wellness opportunities for persons living with disabilities. The sports program recorded over 5800 visits by 490 registered participants, and the fitness program continues to provide services virtually, as well as, in person recording 5,600 one-on-one visits by its 230 registered participants in addition to 5,339 class visits, classes are held in person and virtually. A separate program for youth, the Tengelsen Family Foundation Sports for Kids program, recorded 776 visits by 120 Chicago area children with disabilities. Adaptive Sports and Fitness programs continue to develop community partnerships and collaborations that open doors for people living with a disability to lead an active healthy lifestyle. Vocational Rehabilitation Program: Beginning a career or returning to work following an illness or injury is important to a patient's financial security and emotional well-being. It can contribute to the achievement of a productive, independent and fulfilling life. For more than 50 years, the SRAlab has been providing comprehensive vocational rehabilitation services tailored to meet the needs of each client. Services include initial assessment, vocational counseling and guidance, diagnostic evaluation, work trial assessments, job analysis, return-to-work evaluations, job placement, resume writing, job interview workshops and internship coordination. The SRAlab covers the cost of initial assessments, which are not covered by most third-party payers. Patients receive vocational services at nine SRAlab facilities or via telehealth, ensuring that employment assistance is closely tied to community reintegration. During FY 2024 the program served 1132 clients. In the last year, we placed 96 individuals in jobs. Assistive Technology Programs: The Technology Center and the Wheelchair &amp; Seating Center, comprise SRAlab's Assistive Technology Programs. In FY 2024, the Assistive Technology Programs served approximately 2,888 unique patients. The SRAlab Technology Center provides computer access training, smartphone/tablet access, augmentative communication evaluations/treatment, and electronic aids to daily living, including recommendations for home automation and modifications, for people with different or changing abilities. Occupational therapists and speech language pathologists evaluate and recommend equipment for each individual's needs. Through a lending library, or support from manufacturers facilitated by Technology Center staff, patients can try items before purchasing them or borrow them for short-term use due to changing needs. Staff members speak to universities, schools, organizations for people with disabilities, senior centers and the general public. We also provide continuing education lectures in assistive technology through assistive tech conferences and the SRALAB Academy. The center provides 1 to 2 home visits if the client can no longer come to SRALab following their evaluation. We have also integrated the use of telehealth appointments. Staff recommend applying for SRALab charity funds if Patient's insurance is maxed out. The Technology Center served a total of 1422 clients representing 567 inpatients, 393 Day Rehab clients, and 462 outpatients in the past fiscal year. Rehabilitation Engineering staff collaborate with other allied health clinicians to provide consultation, evaluation, and design of individual solutions to aid persons with different abilities to complete activities of daily living with increased independence at home, work, and in the community. Rehabilitation Engineering involves fabricating custom equipment and modifying commercially available equipment and objects to create unique, individualized solutions to help patients navigate obstacles encountered in daily life. SRAlab provides free care for services and products, and provides real-life design experience to students through Northwestern University's engineering design program. The Wheelchair &amp; Seating Center staff evaluate and make recommendations for complex wheelchairs and customized seating systems for patients with significant mobility and postural needs. This includes manual wheelchairs; powered wheelchairs; custom-made and customized seat and back cushions to relieve pressure, prevent pressure sores, and maintain posture; alternative drive controls like sip and puff and head array systems; that help clients maintain or increase their mobility and independence, at home, work, or in the community. During FY24 the Wheelchair &amp; Seating Center continued to use telehealth appointments to serve our patients that were unable to attend an in person appointment. We served a total of 1466 patients, including 824 inpatients and 642 outpatients this past fiscal year.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 1a</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BYLAWS ALLOW FOR FOUR STANDING COMMITTEES: (i) COMPENSATION AND LEADERSHIP DEVELOPMENT; (ii) FINANCE &amp; AUDIT; (iii) TRANSLATIONAL MEDICINE; AND (iv) INVESTMENT. AN ADVISORY COMMITTEE CONSISTING OF ALL FORMER BOARD CHAIRS SHALL ALSO CONSTITUTE A STANDING COMMITTEE. ADVISORY COMMITTEE MEMBERS PARTICIPATE IN FUNDRAISING ACTIVITIES AND UNDERTAKE SPECIAL ASSIGNMENTS. THE FINANCE AND AUDIT COMMITTEE HAS FINANCIAL OVERSIGHT RESPONSIBILITIES AND CORPORATE INTEGRITY OVERSIGHT. THE INVESTMENT COMMITTEE IS RESPONSIBLE FOR THE MANAGEMENT OF FUNDS AND OVERSEES INVESTMENT POLICY. THE TRANSLATIONAL MEDICINE COMMITTEE IS RESPONSIBLE FOR OVERSIGHT OF TRANSFORMATION OF CLINICAL CARE AND PRACTICE. COMPENSATION AND LEADERSHIP COMMITTEE IS RESPONSIBLE FOR RECOMMENDING COMPENSATION POLICIES AND PROGRAMS AS WELL AS LEADERSHIP AND SUCCESSION PLANNING. IN ADDITION, SPECIAL COMMITTEES MAY BE APPOINTED AS CIRCUMSTANCES WARRANT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 3 Delegation of management duties</FormAndLineReferenceDesc>
        <ExplanationTxt>Crothall Services Group managed our facilities and housekeeping services; Morrison Management Specialists managed our food services, and Pharmacy Systems, Inc. managed our pharmacy. No officers, directors, trustees, or key employees (current or former) received compensation from any of these companies.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 6 Classes of members or stockholders</FormAndLineReferenceDesc>
        <ExplanationTxt>Rehabilitation Institute, Inc. (RII) is the sole corporate member of SRAlab.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 7a Members or stockholders electing members of governing body</FormAndLineReferenceDesc>
        <ExplanationTxt>As the sole corporate member of SRALAB, RII has the following rights, with respect to the organization's governing body: -Appoint all the Directors of the Corporation. -Nominate to the Corporation's Board of Directors all candidates for selection as well as the Corporation's Chairman, Vice Chair(s) and President &amp; Chief Executive Officer.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders</FormAndLineReferenceDesc>
        <ExplanationTxt>As the sole corporate member of the organization, RII shall have powers and voting rights to do the following: (a) appoint all the Directors of the Corporation. (b) Nominate to the Corporation's Board of Directors all candidates for selection as the Corporation's Chairman, Vice Chair(s) and President &amp; Chief Executive Officer. (c) Approve expressly all amendments to the Corporation's articles of incorporation and Bylaws. (d) Approve each annual budget and long-range plan of the Corporation. (e) Approve each annual list of proposed donors and amounts of donations or grants not included in the annual budget, and make proposals to deviate therefrom throughout each year in excess of $50,000. (f) Approve any contract or loan obligating the Corporation to expend or repay an amount in excess of $250,000 which was not included in a previously approved annual budget, shall be subject to Member approval. (g) Approve all plans of merger, consolidation, or voluntary dissolution and the creation of any subsidiary organization. (h) Approve the sale, lease, exchange, mortgage, pledge or other disposition of all or substantially all, the property and assets of the Corporation.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 11b Review of form 990 by governing body</FormAndLineReferenceDesc>
        <ExplanationTxt>First, the Form 990 is prepared internally. Then, a third party tax preparer reviews the Form 990 in its entirety and presents their results to the finance and audit committee . Next, it is reviewed internally by executive leadership. Finally, it is presented electronically to the full Board.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 12c Conflict of interest policy</FormAndLineReferenceDesc>
        <ExplanationTxt>All newly hired employees are required to complete a conflict of interest disclosure form at the time of new-employee orientation. In addition, all employees are required to complete such a form on an annual basis. Directors and Officers complete a Conflict of Interest Questionnaire on an annual basis. THE COMPLIANCE DEPARTMENT REVIEWS ALL DISCLOSURES. THIS DEPARTMENT DETERMINES IF A CONFLICT OF INTEREST EXISTS. IF ONE EXISTS, IT IS DISCUSSED WITH VICE PRESIDENTS AND MANAGED BY THE COMPLIANCE DEPARTMENT. ADDITIONALLY, THIS INFORMATION IS SUMMARIZED AND SHARED WITH THE FINANCE AND AUDIT COMMITTEES OF THE BOARD OF DIRECTORS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 15a Process to establish compensation of top management official</FormAndLineReferenceDesc>
        <ExplanationTxt>The Compensation and Leadership Development Committee of the Board has authority to approve total compensation for the CEO, officers, and key employees; an independent consultant specializing in the field of executive compensation and benefits is hired by the Compensation and Leadership Development Committee of the Board to review and provide an opinion about the executive compensation; namely, that it is fair, reasonable and market appropriate. During the annual review and approval of the total compensation, documentation of the decision related to total compensation for the CEO, officers, and key employees was recorded in the minutes. The individuals involved were not present when their compensation was decided. SRAlab, acting through its Compensation and Leadership Development Committee of the Board, performed all of the above procedures to obtain the rebuttable presumption respecting compensation arrangements (per IRC Section 4958). The process for reviewing and approving compensation is undertaken annually and was last performed in Nov of the tax period covered by this return.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 15b Process to establish compensation of other employees</FormAndLineReferenceDesc>
        <ExplanationTxt>See narrative for Line 15a</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 19 Required documents available to the public</FormAndLineReferenceDesc>
        <ExplanationTxt>The Governing documents, conflict of interest policy and financial statements are made available to the public upon request after thorough consideration for their use.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VIII, Line 2f Other Program Service Revenue</FormAndLineReferenceDesc>
        <ExplanationTxt>Other - Total Revenue: 4355248, Related or Exempt Function Revenue: 4355248, Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: ;</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part XI, Line 9 Other changes in net assets or fund balances</FormAndLineReferenceDesc>
        <ExplanationTxt>Pension Adjustment - 11785542; Interest Rate Swap - -705591;</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="IRS990ScheduleR" softwareId="23017437" softwareVersionNum="2023v6.0">
      <IdDisregardedEntitiesGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>Medical Services SRALAB</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>355 East Erie Street</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <EIN>911999919</EIN>
        <PrimaryActivitiesTxt>Physician Practice Billing and Collections</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>IL</LegalDomicileStateCd>
        <TotalIncomeAmt>0</TotalIncomeAmt>
        <EndOfYearAssetsAmt>0</EndOfYearAssetsAmt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>Shirley Ryan Abilitylab</BusinessNameLine1Txt>
        </DirectControllingEntityName>
      </IdDisregardedEntitiesGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>Rehabilitation Institute Inc</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>355 East Erie Street</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <EIN>363310838</EIN>
        <PrimaryActivitiesTxt>Parent</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>IL</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(c)(3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>Type II</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NA</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>Pathways Foundation</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>355 East Erie Street</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <EIN>522456469</EIN>
        <PrimaryActivitiesTxt>Rehabilitation Services</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>IL</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(c)(3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>Type I</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>Rehabilitation Institute of Chicago dba Shirley Ryan AbilityLab</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>Rehabilitation Institute of Chicago Medical Rehabilitation Enterprises</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <USAddress>
          <AddressLine1Txt>355 East Erie Street</AddressLine1Txt>
          <CityNm>Chicago</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <EIN>363428852</EIN>
        <PrimaryActivitiesTxt>Inactive</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>IL</LegalDomicileStateCd>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>Rehabilitation Institute Inc (RII)</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <EntityTypeTxt>C Corporation</EntityTypeTxt>
        <ShareOfTotalIncomeAmt>0</ShareOfTotalIncomeAmt>
        <ShareOfEOYAssetsAmt>0</ShareOfEOYAssetsAmt>
        <OwnershipPct>0</OwnershipPct>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>false</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>false</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>false</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>false</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>false</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>false</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>false</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>false</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>false</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>false</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>false</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>false</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>false</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>true</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>true</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>false</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>true</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>false</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>false</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>PATHWAYS FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>Q</TransactionTypeTxt>
        <InvolvedAmt>1777823</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Book Value</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>PATHWAYS FOUNDATION</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>N</TransactionTypeTxt>
        <InvolvedAmt>165996</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>Book Value</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
    </IRS990ScheduleR>
  </ReturnData>
</Return>